United States .FINAL
Environmental Protection ECAO-CIN-001 2
Agency August. 1988
-^ __~ - ^Z K • Hev^sed Uecember , iyy
oEPA Research and
Development
DRINKING WATER CRITERIA DOCUMENT
FOR TRICHLOROBENZENES
Prepared for
OFFICE OF WATER
Prepared by
Environmental Criteria and Assessment Office
Office of Health and Environmental Assessment
U.S. Environmental Protection Agency
Cincinnati, OH 45268
DRAFT: 00 NOT CITE OR QUOTE
NOTICE
This document I* a preliminary draft. It has not been formally released
by the U.S. Envlroraental Protection Agency and should not at this stage be
construed to represent Agency policy. It Is being circulated for comments
on Its technical accuracy and policy Implications.
-------
DISCLAIMER
This document has been reviewed 1n accordance with the U.S. Environ-
mental Protection Agency's peer and administrative review policies and
approved for publication. Mention of trade names or commercial products
does not constitute endorsement or recommendation for use.
11
-------
FOREWORD
Section 1412 (b)(3)(A) of the Safe Drinking Water Act, as amended In
1986, requires the Administrator of the Environmental Protection Agency to
publish maximum contaminant level goals (MCLGs) and promulgate National
Primary Drinking Water Regulations for each contaminant, which, In the
judgment of the Administrator, may have an adverse effect on public health
and which Is known or anticipated to occur In public water systems. The
MCLG Is nonenforceable and Is set at a level at which no known or antici-
pated adverse health effects 1n humans occur and which allows for an
adequate margin of safety. Factors considered 1n setting the HCLG Include
health effects data and sources of exposure other than drinking water.
This document provides the health effects basis to be considered 1n
establishing the NCLG. To achieve this objective, data on pharmacoklnetlcs,
human exposure, acute and chronic toxlclty to animals and humans, epidemi-
ology and mechanisms of toxlclty are evaluated. Specific emphasis Is placed
on literature data providing dose-response Information. Thus, while the
literature search and evaluation performed In support of this document has
been comprehensive, only the reports considered most pertinent In the deri-
vation of the MCLG are cited In the document. The comprehensive literature
data base In support of this document Includes Information published up to
1985; however, more recent data may have been added during the review
process. Editorial changes were also made In 1991 when this document was
finalized.
When adequate health effects data exist, Health Advisory values for less
than lifetime exposures (1-day, 10-day and longer-term, ~10X of an
Individual's lifetime) are Included In this document. These values are not
used 1n setting the MCLG, but serve as Informal guidance to municipalities
and other organizations when emergency spills or contamination situations
occur.
Tudor Davis, Director
Office of Science and
Technology
James Elder, Director
Office of Ground Water
and Drinking Water
111
-------
DOCUMENT DEVELOPMENT
W. Bruce Pelrano, Document Manager and Principal Author
Environmental Criteria and Assessment Office, Cincinnati
U.S. Environmental Protection Agency
John Clcmanec, Assistant Document Manager
Environmental Criteria and Assessment Office, Cincinnati
U.S. Environmental Protection Agency
Special Note: This document was developed from the comprehensive Informa-
tion found In the Health Assessment Document for Chlorinated
Benzenes (EPA 600/8-84-015F).
Internal Scientific Reviewers and Contributors
David J. Relsman
Environmental Criteria and Assessment Office, Cincinnati
U.S. Environmental Protection Agency
Charles H. R1s III
Carcinogen Assessment Group, Washington, DC
U.S. Environmental Protection Agency
Seong T. Hwang
Exposure Assessment Group, Washington, DC
U.S. Environmental Protection Agency
Herbert H. Cornish
Ypsllantl. Michigan
Norman M. TMeff
University of Texas Medical Branch
Galveston, Texas
Shane S. Que Hee
Department of Environmental Health
University of Cincinnati
Cincinnati. Ohio
William L. Marcus
Office of Drinking Water, Washington, DC
U.S. Environmental Protection Agency
1v
-------
Editorial Review
Erma R. Durden
Judith A. Olsen
Environmental Criteria and Assessment Office, Cincinnati
U.S. Environmental Protection Agency
Document Preparation
Technical Support Services Staff, Environmental Criteria and Assessment
Office, Cincinnati
-------
TABLE OF CONTENTS
Page
I. SUMMARY 1-1
II. PHYSICAL AND CHEMICAL PROPERTIES II-l
CHEMICAL ANALYSIS II-6
Chemical Analysis 1n Water II-7
Chemical Analysis 1n Soil, Sediment and Chemical
Waste Disposal Site Samples II-7
Chemical Analysis In Fish and Other Foods II-7
Chemical Analysis In Air . . II-8
SUMMARY II-9
III. TOXICOKINETICS III-l
ABSORPTION IH-1
DISTRIBUTION III-1
METABOLISM III-2
EXCRETION III-6
SUMMARY III-9
IV. HUMAN EXPOSURE IV-1
V. HEALTH EFFECTS IN ANIMALS V-l
ACUTE TOXICITY V-l
SUBCHRONIC TOXICITY V-6
CHRONIC TOXICITY V-15
MUTAGENICITY V-17
CARCIN06ENICITY V-18
REPRODUCTIVE AND TERATOGENIC TOXICITY V-19
SUMMARY V-21
VI. HEALTH EFFECTS IN HUMANS VI-1
SUMMARY VI-1
VII. MECHANISMS OF TOXICITY VII-1
SUMMARY VII-3
vl
-------
TABLE OF CONTENTS (cont.)
Page
VIII. QUANTIFICATION OF TOXICOLOGIC EFFECTS VIII-1
INTRODUCTION VIII-1
NONCARCINOGENIC EFFECTS V11I-6
QUANTIFICATION OF NONCARCINOGENIC EFFECTS VIII-7
Derivation of 1-Day HA VIII-7
Derivation of 10-Day HA VIII-12
Derivation of Longer-term HA VIII-14
Assessment of Lifetime Exposure and Derivation of
a DWEL VIII-18
CARCINOGENIC EFFECTS VIII-19
EXISTING GUIDELINES, RECOMMENDATIONS AND STANDARDS VIII-19
Occupational VIII-19
Transportation and Regulations VIII-20
Solid Waste Regulations VIII-20
Water VIII-21
SUMMARY VIII-21
IX. REFERENCES IX-1
vll
-------
LIST OF TABLES
No. Title
II-l Synonyms, Trade Names and Identification Numbers of
the Trlchlorobenzenes H-3
II-2 Physical Properties of the Trlchlorobenzenes II-4
II-3 Vapor Pressures and Vapor Densities of the
Trlchlorobenzenes H-5
III-l Distribution of "C-Labeled 1,2.4-Trlchlorobenzene
1n Rat Tissues After Oral Dosing with 181.5 mg/kg/day
for 7 Days IH-3
V-l Summary of Subchronlc and Chronic Toxldty Studies
on Trlchlorobenzenes V-7
VIII-1 Summary of Subchronlc and Chronic Toxldty Studies
on Trlchlorobenzenes VIII-8
VIII-2 Toxlclty Data for Threshold Estimates VIII-10
VIII-3 Summary of the Data for 1,2,4-Trlchlorobenzene Used
to Derive HA and DWEL VIII-22
vlll
-------
LIST OF ABBREVIATIONS
BUN Blood urea nHrogen
DUEL Drinking water equivalent level
EPN O-ethyl-0-p-nltrophenyl phenylphosphothlonate
G-6-P Glucose-6-phosphatase
GC Gas chromatography
GC/MS Gas chromatography/mass spectrometry
GI Gastrointestinal
1.p. IntraperUoneal
1.v. Intravenous
LDH Lactic dehydrogenase
LOAEL Lowest-observed-adverse-effect level
NOAEL No-observed-adverse-effect level
NOEL No-observed-effect level
RfD Reference dose
SAP Serum alkaline phosphatase
SGOT Serum glutamlc oxaloacetlc transamlnase
SGPT Serum glutamlc pyruvlc transamlnase
wt Height
1x
-------
I. SUMMARY
The trlchlorobenzenes are a group of three chemical Isomers In which
three chlorine atoms have been added to a benzene ring. The 1,2,3- and
1,3,5-trlchlorobenzenes are normally solid while 1,2,4-tr1chlorobenzene 1s
normally a liquid at 25°C. The trlchlorobenzenes are only slightly solu-
ble In water (6.6-34.6 mg/l at 25CC). The trlchlorobenzenes are produced
In relatively small amounts (1.3-7 million kg/year) and are used primarily
as chemical Intermediates, solvents, Insecticides, and coolants and Insula-
tors In electrical equipment. Analysis of the trlchlorobenzenes In water
normally Involves a solvent extraction and cleanup method followed by gas
chromatography (GC) or gas chromatography/mass spectrometry (GC/HS)
analysis. The water analysis methods are slightly modified for analysis of
trlchlorobenzenes In soil and food.
The limited comparative pharmacoklnetlc data available on the
trlchlorobenzenes prevent specification of the absorption, distribution,
metabolism and excretion of the Individual Isomers. The trlchlorobenzenes
appear to enter the systemic circulation readily by Inhalation, Ingestlon
and dermal absorption; however, data were not available to quantltate the
rates of these processes nor of any of the pharmacoklnetlc processes.
Initial distribution of the trlchlorobenzenes and metabolites Is mainly to
the liver, kidneys and adrenals, followed by migration to adipose tissue or
metabolism to polar compounds that are more readily excreted. From the
available data, It seems relatively clear that metabolism In at least three
species has a common first step, the production of an arene oxide Inter-
mediate. Subsequent metabolic steps, however, vary among the species
examined, at least for the most studied Isomer, 1,2,4-trIchlorobenzene.
03720 1-1 04/05/91
-------
In general, the pharmacoklnetlcs of the tMchlorobenzencs are similar to
those described for the other halogenated anomalies. These compounds arr
Upophlllc and their metabolism and excretion depends on their conversion to
polar Intermediates. In addition, their Upophlllc character provides for
ready absorption from the gastrointestinal tract and Initial distribution to
the more highly perfused tissues, particularly the liver, kidneys and
adrenal and thyroid glands, after which they arc either metabolized and
excreted or redistributed to adipose tissue or skin. Additional experiments
are needed to clarify the relationship of these studies to the metabolism of
trlchlorobenzenes In humans.
The effects In mammals of acute exposure by various loutcs to trlchloro-
benzenes Include local Irritation, convulsions and death. Livers, kidneys,
adrenals, mucous membranes and brain ganglion cells appear to be target
organs with effects Including edema, necrosis, fatty Infiltration of livers,
Increased organ weights, porphyrin Induction and mlcrosomal enzyme Induction.
Quantitative data on the toxic effects of trlchlorobenzene following
subchronlc exposure by various routes were obtained in a variety of
species. In general, these studies Indicate that the liver, kidney, adrenal
glands and thyroid glands are target organs. Oral gavage of
1,2,4-tr1chlorobenzene at 53.5 mg/kg (10 ppm) for 95 days Induced
vacuollzatlon of the zona fasdculata of the adrenal cortex In several
rats. One study Identified 14.8 mg/kg/day of 1,2,4-tMchlorobenzene as a
no-observed-adverse-effect level (NOAEL) In rats, while another study
reported that some rats exposed by Inhalation to 1,3,5-trlchlorobenzene at
1000 mg/m3 for 13 weeks showed squamous metaplasia and focal hyperplasla
03720 1-2 01/03/92
-------
of the respiratory epithelium, which appeared to be reversible. Subchronlc
oral studies have also shown that the trlchlorobenzenes Induce transient
hepatic xenoblotlc metabolism and porphyrla. Subchronlc dermal exposure
resulted In mild to moderate Irritation .
One chronic study, on the effects of tMchlorobenzene painted on the
skin of mice for 2 years, reported Increased mortality In females at the low
dose (30X solution In acetone) and In both sexes at the high dose (60% solu-
tion).
Results of two reports on mutagenlclty tests with Salmonella typhlmurlum
test strains were negative. However, this test system Is generally Insensi-
tive to chlorinated compounds. One cardnogen1c1ty study, a 2-year skin
painting study In mice, failed to demonstrate a conclusive tumoMgenlc ef-
fect. A multlgeneratlon study of the reproductive effects of oral exposure
of rats to trlchlorobenzene failed to show effects on reproduction. Oral
teratogenlclty studies In rats showed mild osteogenlc changes In pups and
significantly retarded embryonic development as measured by fetal growth
parameters.
Human exposure to 1,2,4-trlchlorobenzene at 3-5 ppm causes eye and res-
piratory Irritation. The only other data on human exposure are Individual
case reports of aplastlc anemia of persons exposed occupatlonally or domes-
tically.
No health advisories (HAs) or lifetime drinking water equivalent levels
(DWELs) are suggested for the 1,2,3- and 1,3,5-trfchlorobenzene Isomers
because of Insufficient data being available for evaluation.
03720 1-3 12/23/91
-------
The 1-day HA for 1,2,4-trlchlorobenzene of 1 mg/l for a 10 kg child Is
based on a study In which female Wlstar rats were given single oral doses of
1,2,4-trkhlorobenzene and were then evaluated 24 hours later. The 10-day
HA for 1,2,4-tr khlorobenzene of 1 mg/ft for a 10 kg child Is based on a
study In which male CD rats were given 1,2,4-tr khlorobenzene for 14 days
and were then evaluated for effects. The longer-term HAs for
1,2,4-trlchlorobenzene of 1 mg/l for a 10 kg child and 5 mg/a for a 70
kg adult are based on a study In which CD-I rats were exposed orally to
1,2,4-trkhlorobenzene for 95 days and evaluated for reproductive effects
and organ weight changes. A DUEL for 1,2,4-trlchlorobenzene of 0.4 mg/a
for a 70 kg adult Is derived from an RfD of 0.01 mg/kg/day (verified
12/12/91) from the same 95-day reproductive study. The data available on
1,2,4-trlchlorobenzene Is Inadequate for making any conclusions about Us
potential carclnogenklty In humans. The trlchlorobenzenes are classified
as U.S. EPA Group D compounds at this time, that Is, available data are
Insufficient. This Information was verified by the CRAVE workgroup 1n
October 1988.
03720 I 4 01/03/92
-------
II. PHYSICAL AND CHEMICAL PROPERTIES
The trlchlorobenzenes are a group of three chemical Isomers In which
three chlorine substltuents have been added to a benzene ring. The
trlchlorobenzenes are only slightly soluble In water (6.6-34.6 mg/l at
25°C). The trlchlorobenzenes are produced 1n relatively small amounts
(1.3-7 million kg/year Is the estimated 1983 production) (U.S. EPA, 1983;
Chlorobenzene Producers Association. 1984) and are used primarily as chemi-
cal Intermediates, solvents. Insecticides, and coolants and Insulators 1n
electrical equipment (Hawley, 1977; Sllmak et al., 1980). Trlchlorobenzenes
have been detected In all environmental media Including drinking water, and
have been found to bloaccumulate In fish (U.S. EPA, 1985). In addition to
the exposure of humans during the manufacture and use of trlchlorobenzenes,
exposure could result from Inhalation of contaminated air and Ingestlon of
contaminated food and water.
The chemical structures of the trlchlorobenzenes are shown In Figure
II-l. Synonyms, trade names and Identification numbers for the trlchloro-
benzenes are found In Table II-l. Some of the physical and chemical proper-
ties of the trlchlorobenzenes are found In Tables II-2 and II-3. 1,2,3-Trl-
chlorobenzene 1s a white crystalline solid (platelets from alcohol) that Is
volatile with steam. It Is slightly soluble (31.5 mg/i) at 25°C 1n water,
slightly soluble In alcohol, soluble 1n benzene and carbon dlsulflde, and
very soluble 1n ether (NLM. 1981a; Yalkowsky and Valvanl. 1980).
1.2,4-Trlchlorobenzene 1s a colorless liquid at 25°C but at somewhat
reduced temperatures may also take the form of rhombic crystals because Us
03730 II-l 09/12/88
-------
Cl
Cl
Cl
1.2,3-TRICHLOROBENZENE 1,2,4-TRICHLOROBENZENE 1,3,5-TRICHLOROBENZENE
FIGURE II-l
Chemical Structures of the TMchlorobenzenes
03730
II-2
09/24/85
-------
TABLE II-l
Synonyms, Trade Names and Identification Numbers of the Trlchlorobenzenes*
Chemical
Identification Number
Synonyms and Trade Names
1.2,3-
1,2.4-
1.3,5-
CAS No. 87-61-6
CAS No. 120-82-1
TSL No. DC2100000
CAS No. 108-70-3
v1c-Tr1chlorobenzene
1,2,6-Trlchlorobenzene
v-Tr1chlorobenzene
Benzene, 1,2,4-trlchloro-
asym-Trlchlorobenzene
TCB
Trojchlorobenzen (Polish)
1,2,4-TMchlorobenzol
Hostetex L-Pec
s-Tr1chlorobenzene
sym-Trlchlorobenzene
TCB
TCBA
Benzene, 1,3,5-trlchloro-
*Source: NLM, 1981a.b, Toxicology Data Bank (TDB)
03730
II-3
09/25/85
-------
{ 11-2
Physical Properties of the Trlchlorobenrenes*
0
0
Cheatcal
Trlchlorobenzene
1.2.3-
1.2.4-
1.3.5-
Holecular
Height
181.46
181.46
181.46
Helling
Point
CC)
52.6
16.95
63.4
Boiling
Point0
221
213.5
208.4
Dens1tyc
(g/flft)
1.69
1.45
1.39(64)1
Henry's Law
Constant x 1(T» Log P°d
(aim n* mol'1)
1.0d 4. 1*
1.42h 4.12*
NA NA
Hater
Solubility
(ng/t)e
31.59
34.69 ,
6.69
Flash
Point
CO
113
110
107
Index of
Refraction
at CC)
1.5776(19)
1.5717(20)
1.5662(19)
'Data are fro* the NLH. 1981 a,b, Toxicology Data Bank (TDB). except as noted.
>>At 760 on
CAI 20*C. except as noted
facKay et al.. 1979
*At K"t
flsoaer unspecified
flValkowsky and Valvanl. 1980
*>Uarner et al.. 1980
'Hansch and Leo. 1981
JHorvath, 1982
P» . Octanol/water partition coefficient at 25*C
NA . Not available
CO
CO
-------
TABLE I1-3
Vapor Pressures and Vapor Densities of the Trlchlorobenzenes
Chemical Vapor Pressure Specific Vapor Density
(mm Hg) (air = 1)
TMchlorobenzene
1.2,3-
1.2,4-
1.3,5-
0.07 at 25°Ca
1 at 40°Cb
0.29 at 25°Ca
1 at 38.4°Cb
0.15 at 25°Ca
10 mm at 78°Cb
6.26b
6.26b
6.26b
aNLM, 1981a,b; 1982
bSax, 1979
03730 II-5 09/24/85
-------
melting point occurs at 16.95°C. It possesses a distinctive odor, similar
to that of l,4-d1chlorobenzene, and 1s considered volatile with steam (NLM,
19815). It Is slightly soluble In water, 34.6 mg/i at 25°C (Yalkowsky and
Valvanl, 1980); mlsclble with benzene, petroleum ether and carbon dlsulflde;
slightly soluble In ethanol; and very soluble In dlethyl ether (NLM, 1981b).
The summer sunlight photolysis half-life for 1,2,4-trlchlorobenzene In
surface waters at 40° latitude has been calculated to be 450 years (Dulln et
al., 1986). An Information sheet (Dow Chemical Company, 1979-1980) listed a
purity of 100X for Its product. Kao and Poffenberger (1979) reported that
commercial 1,2,4-trlchlorobenzene may contain monochlorobenzene (<0.1 wt
percent) and d1- and tetrachlorobenzenes (<0.5 wt percent and <0.5 wt
percent) with the 1,2,4-trlchlorobenzene content being -97%.
1,3,5-Trlchlorobenzene takes the physical form of white crystals or
needles. It Is very slightly soluble (6.6 mg/l at 25°C) In water;
sparingly soluble In alcohol; and soluble 1n ether, benzene, petroleum
ether, carbon dlsulflde and glacial acetic acid (NLM, 1982; Yalkowsky and
Valvanl. 1980).
Chemical Analysis
A solvent extraction and cleanup method followed by GC or GC/MS 1s the
most commonly used method to Isolate trlchlorobenzenes from water. Methods.
that are slightly modified from the analytical procedures for aquatic
samples are used for the analysis of trlchlorobenzenes In soil and food.
The usual sampling and analytical methods for airborne trlchlorobenzenes
Involve the adsorption and concentration of airborne vapors on sorbent-
packed cartridges followed by thermal desorptlon and GC analysis using
03730 II-6 09/12/88
-------
either flame 1on1zat1on detection, electron capture (EC) detection, or
photolonlzatlon detection. The following sections provide examples of these
analytical methods.
Chemical Analysis In Water. The purge-trap technique does not provide
quantitative recoveries for compounds with low volatilities, such as
trlchlorobenzenes. Therefore, a solvent extraction and cleanup method Is
normally used to produce organic extracts suitable for GC/MS analysis. The
U.S. EPA (1982) (Method 612) has recommended the use of Florlsll column
chromatography as a cleanup step before the quantification of the samples by
GC with EC detector. This recommended method 1s applicable for the
determination of trlchlorobenzenes 1n drinking water and wastewater.
Chemical Analysis 1n Soil. Sediment and Chemical Waste Disposal Site
Samples. The solvent extraction method was used by Lopez-Avlla et al.
(1983) to determine trlchlorobenzenes In sediment samples. In this method,
the solvent extract was subjected to acid-base fractlonatlon. The
base/neutral fraction containing the trlchlorobenzenes was fractionated by
silica gel chromatography. The final separation and quantification was
accomplished by GC/MS. The recovery of 1,2,4-trlchlorobenzene by this
method was 67X at a spike level of 400 ng/g of dry sediment.
Chemical Analysis 1n Fish and Other Foods.
F1sh — The determination of trlchlorobenzenes 1n fish samples can
be accomplished by a solvent extraction method. In one method, Kuehl et al.
(1980) subjected the solvent extract to Florlsll and gel permeation on
chromatographlc separation, followed by GC/MS Identification and quantifica-
tion of trlchlorobenzene 1n fish samples.
03730 II-7 09/12/88
-------
Chemical Analysis In Air. Lewis and MacLeod (1982) have developed and
evaluated a portable low-volume air sampling system for Indoor air monitor-
Ing of sem1vo1at1le organic chemicals. Two types of sampling cartridges
were tested to sample for tHchlorobenzenes. The trlchlorobenzenes were
poorly trapped using a polyurethane foam (PUF) plug, with collection
efficiencies of 6.6%. However, using a dual-sorbent trap consisting of a
0.6 g layer of Tenax-GC (35-60 mesh) sandwiched between two 3.8 cm PUF
plugs, a collection efficiency of 98% was obtained. Theoretical detection
limits, using GC/EC detection, are expected to be at least one order of
magnitude lower (In the range of 0.06-0.1 pg/m3). Storage stability of
the PUF cartridges was tested under adverse storage conditions. The amount
of trlchlorobenzenes recovered from the cartridges after 15 days of storage
at 32°C was 57%. Oehme and Stray (1982), however, reported high recoveries
of 80, 94 and 115% for 1,2,3-, 1,2,4- and 1,3,5-tr1chlorobenzenes, respec-
tively, with PUF plugs.
Langhorst and NestMck (1979) used an air sampling tube packed with two
sections of Amberllte XAD-2 resin separated by a sllanlzed glass wool plug
to collect the trlchlorobenzenes. The adsorbent was desorbed with carbon
tetrachlorlde and analyzed by GC using a photolonlzatlon detector. Using
the method described, the minimum detection limits for the trlchlorobenzenes
were 30 ppb (v/v). Collection and desorptlon efficiencies for the chloro-
benzenes (air concentrations between 5 ppb and 15 ppm) were -95% with a
precision of +12%.
03730 II-8 09/24/85
-------
Summary
The trlchlorobenzenes are a group of three chemical Isomers 1n which
three chlorine substUuents have been added to a benzene ring. The 1,2,3-
and 1,3,5-tr1ch1orobenzenes are normally solid while 1,2,4-tr1chlorobenzene
1s normally a liquid at 25°C. The trlchlorobenzenes are only slightly
soluble 1n water (6.6-34.6 mg/8. at 25°C). The trlchlorobenzenes are
produced 1n relatively small amounts (1.3-7 million kg/year) and are used
primarily as chemical Intermediates, solvents, Insecticides, and coolants
and Insulators 1n electrical equipment. Analysis of the trlchlorobenzenes
1n water normally Involves a solvent extraction and cleanup method followed
by GC or GC/MS analysis. The water analysis methods are slightly modified
for analysis of trlchlorobenzenes 1n soil and food.
03730 I1-9 09/24/85
-------
III. TOXICOKINETICS
Absorption
No quantitative studies on the absorption of the trlchlorobenzenes from
the gastrointestinal tract, skin or lungs were found. Information on
absorption may be obtained from data describing elimination. Male Charles
River rats (16 In the group) excreted a mean of 84X, and two female rhesus
monkeys excreted a mean of 40% of the orally (by gavage) administered dose
of 10 mg 14C-l,2,4-tr1chlorobenzene/kg 1n the 24-hour urine, while fecal
elimination accounted for only 11 and IX, respectively (Llngg et al., 1982).
The results Indicate that 1n these species, this Isomer Is well absorbed
from the gastrointestinal tract. Two Chinchilla female rabbits given doses
of 500 mg 1,3,5-trlchlorobenzene/kg 1n arachls oil by gavage expired -10X of
the administered dose via the lungs over a period of 9 days (Parke and
Williams, 1960). These Investigators also observed elimination of urinary
and fecal metabolites, but quantities or percentages were not reported.
That the trlchlorobenzenes are absorbed by the respiratory tract and by
the skin can be Inferred from systemic effects observed In toxldty studies
using the Inhalation (Kodba et al., 1981) and dermal (Brown et al., 1969)
routes of exposure.. • These studies, however, were not designed to give
Information on rates of absorption.
Distribution
Smith and Carlson (1980) examined the distribution of 14C-1,2,4-tM-
chlorobenzene In groups of four male Sprague-Dawley rats on days 1, 6, 11
and 16 after oral dally dosing with 181.5 mg/kg (1 mmol/kg) 1n corn oil for
03740 III-l 09/26/85
-------
7 days. Their data Indicate that the adrenals Initially had the highest
concentration of racholabel. This level declined rapidly; however, by day
11 H was less than twice the background of the other tissues. Abdominal
fat had the highest concentration at the end of day 1 (Table III-l) and
maintained detectable concentrations (20% of the day 1 level) for the
duration of the observation period (16 days). The liver also maintained
detectable levels throughout the recovery period, retaining -30% of the day
1 level by day 16. These authors also found that starvation for 4 days had
no observed effect on the distribution of l4C-tr1chlorobenzene 1n fat or
liver.
Parke and Williams (1960) reported the distribution of 1,3,5-trlchloro-
benzene 1n one rabbit on day 8 following oral administration of a single
dose of 500 mg/kg as follows: 13% of the administered dose was detected In
the feces. 23% (4X as monochlorobenzene) In the gut. 5% 1n the pelt, 5% In
depot fat (exclusive of pelt) and 22% In the carcass.
Metabolism
No metabolic studies following the Inhalation of trlchlorobenzenes were
available for review, but the metabolic fate following oral and/or Intra-
venous (1.v.) or Intraperltoneal (1.p.) administration has been charac-
terized In rabbits (Jondorf et al., 1955; Parke and Williams. 1960; Kohll et
al., 1976) and 1n rats and monkeys (L1ngg et al.. 1982).
Jondorf et al. (1955), using spectrophotometrlc analysis, studied the
metabolism of all three Isomers of trlchlorobenzene 1n groups of 3 or 4
Chinchilla rabbits given a single oral dose of 500 mg/kg 1n arachls oil.
03740 III-2 09/26/85
-------
TABLE III-l
Distribution of 14C-Labeled 1,2,4-Trlchlorobenzene In Rat Tissues
after Oral Dosing with 181.5 mg/kg/day for 7 Days3
Tissue
Abdominal fat
Liver
Adrenals0
Muscle
Kidney
Heart
Spleen
Day 1
2033+439
1075+87
754+132
400+30
1471+167
438+14
404+14
Activity (dpm/q t1ssue)b
Day 6 Day 11
642+54 342+10
442+22 308+21
246+22 d/
d/
404^43 d/
d/
d/
Day 16
408±39
317.+18
aSource: Smith and Carlson, 1980
bEach value 1s the mean +. SE for 4 rats, except for abdominal fat on day 1,
which was for three rats.
cTotal for both adrenals; they were not weighed.
dvalue less than twice background; further analyses were not performed.
03740 III-3 06/11/85
-------
The results Indicated that the 1,2,3- Isomer was metabolized to 2,3,4-trl-
chlorophenol (TCP), to 3,4,5-TCP to a lesser degree, and to small amounts of
3,4,5-trlchlorocatechol. During the 5 days after administration, 50% of the
dose was excreted In the urine as glucuronlc acid conjugates, 12% as sul-
furlc acid (sulfate) conjugates and 0.3% as 2.3,4-trlchlorophenylmercapturlc
acid. The 5-day urinary metabolites of 1,2,4-trlchlorobenzene were repre-
sented by glucuronlde conjugates (27%), sulfurlc acid conjugates (11%) and
2,3,5- and 2,4,5- trlchlorophenylmercaptuMc add (0.3%). The major phenols
formed were 2,4,5- and 2,3,5-TCP. For the 1,3,5- Isomer. 20% was excreted
as glucuronlde and 3% as sulfurlc add conjugates. No mercapturlc add was
found, 2.4,6-tMchlorophenol was the only phenol detected In the urine, and
some unchanged 1,3,5-trlchlorobenzene was present In the feces. To further
characterize and clarify the metabolic fate of the 1.3,5- Isomer, Parke and
Williams (1960) followed the 9-day urinary excretion 1n 2 or 3 female Chin-
chilla rabbits treated orally with a single dose of 500 mg of the 1so-
mer/kg. For the first 3 days, the rabbits eliminated 2,4,6-TCP along with
some minor monochlorophenols, while from day 4 to 9, 4-chlorophenol was
detected more prominently along with 2,4,6-TCP and -1% of the dose as
4-chlorocatechol.
Using GC/MS analysis, KohH et al. (1976) examined the metabolism of the
three trlchlorobenzene Isomers following a single 1.p. Injection of 60-75
mg/kg doses In vegetable oil to male rabbits (number and strain not
reported). In agreement with the results of Jondorf et al. (1955), the
major urinary metabolites of 1.2,4-tMchlorobenzene were 2,4,5- and
2,3,5-TCP. The major metabolite of 1,2,3-trlchlorobenzene was 2,3,4-TCP,
with 2,3,6- and 3,4,5-TCP as minor urinary metabolites. The 1,3,5- Isomer
03740 II1-4 09/12/88
-------
was metabolized to 2,3,5- and 2,4,6-TCP and a third, more polar metabolite,
was tentatively Identified as a dlchlorobenzene with 2 hydroxyl and 1
methoxyl substHuents.
Llngg et al. (1982) Investigated the metabolism of 1,2,4-trlchloroben-
zene In groups of 16 male Charles River rats and groups of 2 female rhesus
monkeys following a single oral or l.v. administration of 10 mg/kg doses and
found similar phenolic metabolites to those observed In the rabbit. These
researchers were also able to characterize some species specific conjugates.
An Isomerlc pair of 3.4,6-tr1chloro-3.5-cyclohexad1ene-l,2-d1ol glucuronldes
accounted for 48-61X of the 24-hour urinary metabolites In the monkeys.
Also found were glucuronldes of 2,4,5- and 2,3,5-TCP and unconjugated TCP,
which accounted for 14-37 and 1-37X of the urinary metabolites, respec-
tively. In the rat, the 2.4,5- and 2,3,5- Isomers of N-acetyl-S-(tr1chloro-
phenyl)-L-cyste1ne accounted for 60-62% of the urinary metabolites. Minor
urinary metabolites Included 2,4,5- and 2,3,5-trlchlorothlophenol and free
2,3,5- and 2,3,4-TCP, which accounted for 28-33 and 1-1 OX of the material
excreted, respectively.
On the basis of the studies of Llngg et al. (1982) and Kohll et al.
(1976), H 1s apparent that there may be differences among species In the
metabolism of 1,2,4-tMchlorobenzene. It seems likely that these differ-
ences will extend to the other Isomers of tHchlorobenzene as well. Both
reports postulated the same first step 1n metabolism (I.e., Initial forma-
tion of arene oxide Intermediates), but Indicated differences 1n the subse-
quent metabolic reactions. In the rat, conjugation of the Intermediate with
glutathlone was postulated to account for the sulfur-containing urinary
03740 111-5 06/11/85
-------
metabolites. In the monkey, hydrolysis of the arene oxide to the dlhydro-
diol and the absence of sulfur-containing metabolites seemed to preclude the
Involvement of glutathlone (L1ngg et al., 1982). As proposed by Kohll et
al. (1976) and Illustrated In Figure III-l, formation of the Isomerlc trl-
chlorophenols from the arene oxide Intermediates can proceed either by
direct opening of the C-0 bond or by the NIH shift of chlorine.
Differences In the rate of metabolism of the different Isomers within a
species have been attributed to the positions of the chlorine atoms on the
benzene ring, with the presence of two adjacent unsubstHuted carbon atoms
facilitating the formation of the arene oxide Intermediate. Kalogenated
benzenes without adjacent unsubstltuted carbons may still be metabolized via
an arene oxide Intermediate but at a reduced rate, and should show evidence
of a NIH shift (Matthews and Kato, 1979).
Excretion
Llngg et al. (1982) measured the 24-hour excretion of radioactivity 1n
the urine and feces of 16 male Charles River rats and 2 rhesus monkeys given
a single 10 mg/kg l.v. or oral dose of i4C-l,2,4-tr1chlorobenzene. In the
rat, 84X of the oral dose and 78X of the l.v. dose were excreted In the
urine by 24 hours; 11 and 7X, respectively, were the amounts Identified In
the feces In the same period. In the monkeys, 4OX of the oral dose and 22%
of the Injected dose'appeared In the urine and <1% In the feces. Smith and
Carlson (1980) orally administered 181.5 mg/kg/day (1 mmol/kg/day) of
14C-l,2,4-tr1chlorobenzene In corn oil to 4 Sprague-Dawley rats for 7 days
and followed the excretion of radioactivity In the feces and In the urine
during administration and up to 21 days after the first dose. Fecal elimi-
nation rose slightly during the first 3 days of dosing, after which 1t
03740 III-6 09/26/85
-------
1. 1. 3-TCB
\
Cl
OH
Cl
I I i-IW
\
Cl
1 4- ICP
\
HO
Cl
1 « i-t«
Cl' ^N^^ ^Cl
1 I-TCS
a
OH
I « I-TCP
/ \ /
OH
Cl
Cl
1 1 S-1CP
MO
Cl
I 4 S-fC*
1CB • TNICNLOIIMiNfiNE
ICf • IHICHLOROMCMOl
00
en
FIGURE III-l
HetaboDc Pathways for Trkhlorobeniene (TCB) Isomers Through
Arene Oxide Intermediates In Rabbits
Source: Adapted from Kohll et al., 1976
-------
declined rapidly and was essentially complete at 15 days of collection,
accounting for -4% of the total dose. Urinary excretion followed a similar
pattern; however, at 21 days after the first dose, radioactivity was still
detectable. Total urinary excretion to this time accounted for ~72X of the
total administered radioactivity. As noted by L1ngg et al. (1982), the
differences In the excretion rate between the rat and monkey may be
attributable to their different pathways of metabolism, since the monkey
required two steps beyond the arene oxide to produce Its urinary metabolite,
while the rat required only one.
Differences In the rates of excretion between the Isomers of trlchloro-
benzene have also been reported. Jondorf et al. (1955) found that rabbits
given oral doses of 500 mg/kg of 1,2,3-, 1,2,4- or 1,3,5-trlchlorobenzene
excreted 78, 42 or 9%, respectively, of the administered dose as monophenols
In the 5-day urine collection.
U.S. EPA (1980), using data from Williams (1959) and Parke and Williams
(1960), estimated the following half-lives of excretion In the rabbit: 2,
5.5 and 8.5 days for 1,2,3-, 1,2,4- and 1,3,5-trlchlorobenzene, respec-
tively. The rate of metabolism and subsequent excretion Is most likely
related to the position of the chlorine atoms on the benzene ring. Matthews
and Kato (1979) hypothesized that two adjacent unsubstltuted carbon atoms
facilitate the formation of the arene oxide Intermediate and Increase the
rate of metabolism and excretion.
03740 II1-8 08/24/88
-------
Summary
The limited comparative pharmacoklnetlc data available on the trlchloro-
benzenes prevent specification of the absorption, distribution, metabolism
and excretion of the Individual Isomers. The tMchlorobenzenes appear to
enter the systemic circulation readily by Inhalation, 1ngest1on and dermal
absorption; however, data were not available to quantUate the rates of
these processes nor of any of the pharmacoklnetlc processes. Initial dis-
tribution of the trlchlorobenzenes and metabolites Is mainly to the liver,
kidneys and adrenals, followed by migration to adipose tissue or metabolism
to polar compounds that are more readily excreted. From the available data,
It seems relatively clear that metabolism In at least three species has a
common first step, the production of an arene oxide Intermediate. Subse-
quent metabolic steps, however, vary among the species examined, at least
for the most studied Isomer, 1,2,4-trUhlorobenzene.
In general, the pharmacoklnetlcs of the trlchlorobenzenes are similar to
those described for the halogenated aromatlcs by Matthews and Kato (1979).
The authors observed that these compounds are Upophlllc and that their
metabolism and excretion depends on their conversion to polar Intermedi-
ates. In addition, their Upophlllc character provides for ready absorption
from the gastrointestinal tract and Initial distribution to the more highly
perfused tissues, particularly the liver, after which they are either metap-
ollzed and excreted or redistributed to adipose tissue or skin. Additional
experiments are needed to clarify the relationship of these studies to the
metabolism of trlchlorobenzenes In humans.
03740 III-9 09/26/85
-------
IV. HUNAN EXPOSURE
This chapter will be submitted by the Science and Technology Branch,
Criteria and Standards Division. Office of Drinking Water.
03750 IV-1 06/11/85
-------
V. HEALTH EFFECTS IN ANIMALS
Acute ToxIcUv
Studies of the acute toxlclty of the trlchlorobenzenes have been
performed In several species using various routes of administration.
Information on the effects of acute Inhalation exposure to trlchloroben-
zenes Is limited. In an abstract of a study from the Russian literature
(Gurfeln and Pavlova, 1960), a single high Inhalation exposure (exposures of
0.005-0.01 mg/8, In air or 5-10 mg/m3 were used) of an unspecified Isomer
of trlchlorobenzene to rats resulted In Immediate nervousness, and plnkness
of mouth, ears and paws. These effects were followed by convulsions and
death within 30 minutes. wUh edema of livers and kidneys observed upon
necropsy. Unpublished results of a study performed by Treon (1950) were
reported by Coate et al. (1977) and Indicated that the target organs of non-
lethal acute Inhalation exposure to trlchlorobenzenes (a weight-to-weight
mixture of 854 1,2,3- and 92X 1,2,4-trlchlorobenzene) In cats, dogs, rats,
rabbits and guinea pigs Included the liver, ganglion cells at all levels of
the brain, and mucous membranes. Lethal doses resulted In local Irritation
of the lungs and functional changes 1n respiration In animals dying after
exposure. Levels and duration of exposure were not given.
Brown et al. (1969) reported the single-dose oral LD5Q for 1,2,4-trl-
chlorobenzene In CFE rats to be 756 mg/kg (95X confidence limits 556-939
mg/kg). In CF mice, the single-dose oral LD_0 was 766 mg/kg (95X confi-
dence limits 601-979 mg/kg). Death occurred within 5 days In rats and 3
days 1n mice.
03760 V-l 09/12/88
-------
Rlmlngton and Zlegler (1963) studied the porphyrla-lnduclng ability of
1,2,4- and 1,2,3-trlchlorobenzenes administered by gavage to male albino
rats for various time periods (5-15 days). Doses of the Isomers were gradu-
ally Increased until porphyrln excretion was high but fatalities were few.
Porphyrla was Induced by 1,2,4-tMchlorobenzene when the Isomer was given
for 15 days at 730 mg/kg (3 rats) as evidenced by peak elevations In urinary
coproporphyrln, uroporphyrln, porphoblUnogen and i-am1nolevul1n1c add.
At a dose of 500 mg/kg for 10 days (1n 5 rats), peak liver levels of copro-
porphyrln, protoporphyrln, uroporphyrln and catalase were reached. For the
1,2,3-Isomer, urinary excretion of these Indicators peaked at 785 mg/kg for
7 days (3 rats), but to a lesser extent than for the 1,2,4-lsomer. Only the
liver uroporphyrln levels were Increased by administration of 1,2,3-tM-
chlorobenzene at this dose and duration. Glutathlone was found to have a
protective effect on tMchlorobenzene-lnduced porphyrla.
Brown et al. (1969) determined the single-dose percutaneous LO.Q In
CFE rats (4 of each sex) to be 6139 mg/kg (95X confidence limits 4299-9056
mg/kg) for 1,2,4-tr1chlorobenzene administered topically on the shaved
dorsolumbar skin and covered with an Impermeable dressing. All deaths
occurred within 5 days. In skin Irritation studies, 1,2,4-tr1chlorobenzene
was applied to the skin of rabbits and guinea pigs. In the first experi-
ment, two 2x2 cm patches of lint, each containing 1 mi of the compound,
were applied to the shaved backs of rabbits (4 of each sex) for 6 hours/day
for 3 consecutive days and covered with an Impermeable dressing. For
another experiment, rabbits (1 of each sex) and guinea pigs (5 of each sex)
received single uncovered applications of 1,2,4-tr1chlorobenzene on the
shaved mlddorsal skin (1 ml for rabbits, 0.5 mi for guinea pigs) 5
03760 V-2 09/25/85
-------
days/week for 3 weeks. The results Indicated that trlchlorobenzene was not
very Irritating, although HssuHng was noted during the 3-week exposure.
Some guinea pigs that died during the 3-week regimen had focal necrosis of
the liver.
Hepatotoxlc effects (fatty Infiltration and necrosis) were reported by
Cameron et al. (1937) following s.c. and/or 1.v. Injection of 500 mg (range
of doses was 1-500 mg) trlchlorobenzene 1n liquid paraffin to rats; the
toxlclty was less than that of mono- and o-d1chlorobenzene. Further details
of strain, number of animals or Isomers were not reported.
Robinson et al. (1981), In an acute toxlclty study to assess the
Increased adrenal weight that was noted 1n a multlgeneratlon study, admin-
istered to groups composed of 9-10 preweanlng female Charles River rats 1.p.
Injections of 0, 250 or 500 mg of 1,2,4-trlchlorobenzene/kg In corn oil at
22, 23 and 24 days of age. Significant changes (p<0.05) from control values
were observed upon necropsy at 25 days of age as follows: decreased body
weight and Increased adrenal weight at the high dose; decreased uterus and
Increased liver weights at both doses.
Male Holtzman rats (number not specified) were given single Intraperl-
toneal Injections of 1,2,4- or 1,3,5-tMchlorobenzene at a dose of 37 mg/kg
(5 mmol/kg) as a 50X solution 1n sesame oil In a volume of 1 ml/kg (Yang
et al., 1979). Controls received an equal volume of sesame oil. After 24
hours, the femoral veins and the common bile duct were cannulated. Both
Isomers produced significant Increases (p<0.05) 1n bile duct-pancreatic
fluid (BDPF) flow with the 1,2,4- Isomer being 4 times more effective than
03760 V-3 09/25/85
-------
the 1,3,5- Isomer. SGPT activity was elevated by treatment with 1,3,5-trl-
chlorobenzene and bile Flow was elevated by the 1.2,4- Isomer. Both Isomers
caused a decrease In BDPF protein concentration.
Several studies have demonstrated the ability of the tdchlorobenzenes
to enhance xenoblotlc metabolism. Carlson, In a series of reports (Carlson
and Tardlff, 1976; Carlson, 1977a, 1978, 1981; Smith and Carlson, 1980),
examined the ability of 1,2,4-tMchlorobenzene to Induce a variety of mlcro-
somal functions and enzymes Including cytochrome c reductase, 0-ethyl
0-p-nltrophenyl phenylphosphothlonate (EPN) detoxification, cytochrome
P-450, glucuronyltransferase, benzopyrene hydroxylase and azoreductase. In
a 14-day study by Carlson and Tardlff (1976), dally doses of 1,2,4-trl-
chlorobenzene In corn oil were administered orally to groups of 6 male
albino rats at 10, 20 and 40 rug/kg. All the above functions and enzymes
Increased significantly (p<0.05) except benzopyrene hydroxylase. In a
90-day study by the same Investigators, all the functions and enzyme
activities. Including benzopyrene hydroxylase. Increased significantly
(p<0.05) at 10-40 mg/kg/day and remained significantly elevated after a
30-day recovery period. In a similar study, Smith and Carlson (1980)
administered 1,2,4-trlchlorobenzene at 181.5 mg/kg/day (1 mmol/kg/day) to
rats for 7 days, and measured recovery at 1, 6, 11 and 16 days. EPN
detoxification was still significantly (p<0.05) elevated at 11 days;
p-n1troan1sole demethylatlon at 16 days; cytochrome c reductase at 6 days;
and cytochrome P-450 at 11 days. In a similar study by Carlson (1977a),
14-day administration of 1.3,5-tHchlorobenzene at 100-200 mg/kg/day signif-
icantly (p<0.05) Increased EPN detoxification, UDP glucuronyltransferase,
and cytochrome c reductase, and significantly decreased hepatic G-6-P;
03760 V-4 08/24/88
-------
benzopyrene hydroxylase, azoreductase and serum Isocltrate dehydrogenase
were not significantly affected at 200 mg/kg/day. In the same study, jhn
vivo hepatotoxlclty of carbon tetrachlorlde (one dose of 0.5 ml/kg) was
significantly (p<0.05) enhanced by 14-day pretreatment of rats with
1,2,4-trlchlorobenzene. Glucose-6-phosphatase activity was significantly
(p<0.05) decreased by pretreatment with 1,2,4-trlchlorobenzene at 5
mg/kg/day, and Isocltrate dehydrogenase was decreased by pretreatment at 20
mg/kg/day.
The 1,2,4- Isomer, and to a lesser extent the 1,3,5- Isomer, were also
shown to Induce hepatic esterases (Carlson et al., 1979; Carlson, 1980). In
studies similar to those previously described, rats receiving dally oral
doses of 18.2 mg 1somer/kg (0.1 mmol/kg) for 14 days were killed 24 hours
later and hepatic mlcrosomes were prepared. The l,2,4-1somer was an
effective Inducer of both acetanlllde esterase and acetanlllde hydroxylase,
while the l,3,5-1somer Induced only the esterase and to a lesser degree than
did 1,2,4-trlchlorobenzene (Carlson et al., 1979). The l,2,4-1somer also
Induced hepatic arylesterase, while 1,3,5-tMchlorobenzene did not (Carlson,
1980). Pretreatment of rats with 181.5 mg/kg/day (1 mmol/kg/day) of either
Isomer resulted 1n Induction of procalne esterase (Carlson et al., 1979).
In a series of experiments, Arlyoshl et al. (1975a,b,c) studied the
effects of the trlchlorobenzenes on Induction of hepatic mlcrosomal pro-
teins, phosphollplds and enzymes, especially 1n relation to the activity of
4-am1nolevul1n1c acid synthetase, the rate limiting enzyme 1n the bio-
synthesis of heme. The three trlchlorobenzene Isomers were administered
orally to groups of 2-6 female Hlstar rats at a dose of 250 mg/kg/day for 3
days, after which the rats were killed and mlcrosomes were prepared. The
03760 V-5 09/24/85
-------
results Indicated that trlchlorobenzenes Increased the levels of mlcrosomal
proteins, phosphollplds and cytochrome P-450, and enhanced the activities of
aniline hydroxylase, amlnopyrlne demethylase and i-amlnolevullnlc acid
synthetase, with the 1,2,4-lsomer being the most effective (Arlyoshl et al..
1975a,b). The dose response of these effects to 1,2,4-trlchlorobenzene were
determined (Arlyoshl et al., 1975c) for groups of 2-6 female Wlstar rats
treated orally with single doses of 0, 125, 250, 500, 750, 1000 and 1500
mg/kg. The results Indicated that 24 hours after the administration of the
Isomer, mlcrosomal protein was elevated at >750 mg/kg and glycogen content
was decreased at >500 mg/kg. The activities of amlnopyrlne demethylase and
aniline hydroxylase and the content of cytochrome P-450 were Increased at
>250 mg/kg, as was i-amlnolevullnlc acid synthetase activity.
Subchronlc Toxldtv
The effects of trlchlorobenzene following subchronlc Inhalation, as well
as oral and dermal exposure, have been Investigated In a variety of species.
ToxIcHy data for the trlchlorobenzenes can be found In Table V-l.
Koclba et al. (1981) exposed 20 male Sprague-Dawley rats, 4 male New
Zealand rabbits and 2 male beagle dogs by Inhalation to 1,2,4-trlchloroben-
zene (99.4% pure) at levels of 0, 223 mg/m3 (30 ppm) or 742 mg/m3 (100
ppm) for 7 hours/day, 5 days/week for a total of 30 exposures In 44 days.
There were no significant effects on body weight, hematologic Indices or
serum biochemistry tests. Upon necropsy, gross and comprehensive hlstologlc
examination revealed no significant treatment-related effects In any of the
species. At the 742 mg/m3 level, Increased liver weights were detected In
dogs and rats and Increased kidney weights In rats. Urinary excretion of
03760 V-6 04/05/91
-------
F V-l
Sunary of Subchronlc and Chronic Toxic Ity Studies on Trlchlorobenzenes
CO
-J
o»
o
<
«j
8/81/80
Species Route Dose
Rat Inhalation 10. 100 or
1000 ng/n*
of 1.3.5-TCB
Rats, rabbits. Inhalation 223 or 742 ng/m«
two dogs of 1.2.4-TCB
Rat Inhalation 22.3 or
74.2 ng/n«
of 1.2.4-TCB
Rat Inhalation 186. 371 or
742 ng/m»
of 1.2.4-TCB
Rabbits. Inhalation 186. 371 or
monkeys 742 mg/m*
of 1.2.4-TCB
Monkey oral 1. 5. 25. 90.
125 or 173.6
•g/kg/day
of 1.2.4-TCB
Rat oral 50. 100 or
200 rag/kg/day
of 1.2.4-TCB
Rat oral 10. 20 or
40 ng/kg/day
of 1.2.4-TCB
House oral 600 ppm diet
(0.078 ng/kg/
day) of
1.2.4-TCB
Duration
6 hr/day. 5 day/wk
for up to 13 uk
7 hr/day. 5 day/wk;
total of 30 expo-
sures In 44 days
6 hr/day. 5 day/uk.
3 on
7 hr/day. 5 day/uk.
26 uk
7 hr/day. 5 day/uk.
26 uk
30 days
30. 60. 90 or
120 days
90 days
6 on
Effects Reference
No hepatotoxlclty; three high-dose rats had Sasnore et al.. 1983
squanous metaplasia and focal hyperplasla
of respiratory epithelium, believed to be
reversible
Increase In urinary excretion of porphyrla Koclba et al.. 1981
In exposed rats; Increase In liver weights
In high-dose rats and dogs; Increased kid-
ney weights In high-dose rats
Increase In urinary porphyrln excretion In Uatanabe et al.. 1978
high-dose rats; no effects In 22.3 ng/n»
group
Enlarged hepatocytes and nondose-dependent Coate et al.. 1977
hepatocytes vacuollzatlon. liver granuloma,
biliary hyperplasla and kidney hyaline de-
generation at 4 and 13 uk; no hlstopathology
evident at 26 uk
No treatment related changes at 26 uk Coate et al.. 1977
<25 ng/kg/day - no effects observed; Smith et al., 1978
>90 ng/kg/day - observed toxic Ity and death
Increases In liver weights, liver porphyrlns Carlson. 1977b
and urine porphyrlns. dose and tine related
Increase In llver-to-body weight ratio In Carlson and Tardlff,
high-dose group; changes In enzyme actlva- 1976
tton at all doses
No effects Goto et al.. 1972
-------
TABLE V-l (cont.)
o»
o
Species
Guinea pig
House
Rats
Rats
Route
dermal
dermal
oral
(drinking
water)
oral
Dose
0.5 in/day
of 1.2.4-TCB
0.03 mft/palnt-
Ing of 30 and
60X solution In
acetone of
1.2.4-TCB
25. 100 or
400 ng/t
of 1.2.4-TCB
36. 120. 360 or
1200 mg/kg/day
of 1.2.4-TCB
Duration
5 day/wk. 3 wk
2 tlnes/wk. 2 yr
F0 to F2
generations
days 9-13 of
gestation
Effects
Death following extensor convulsion; livers
showed necrotlc foci
Painting Induced excitability, panting and
epidermal thickening, Inflammation and
keratlnlzatlon; Increased organ weights and
mortality
Enlarged adrenals In FQ and FI generations
1200 ng/kg dose all dead by the 3rd day.
360 ng/kg dose caused 22Jt mortality In
dams and moderate hepatocellular hyper-
Reference
Brown et al.. 1969
Vamamoto et al.. 1982
Robinson et al.. 1981
Kltchln and Ebron.
1983
CD
Rabbits
dermal 30. 150 or
450 mg/kg/day
of 1.2.3-TCB
(30%) and 1.2.4-
TCB (70X)
5 day/wk. 4 wk
trophy and non-significant Increases In
embryonic lethality and significantly
retarded embryonic development. 36 and
120 mg/kg groups not observed for embryonic
effects, but slight hepatocellular hyper-
trophy was reported In one 120 mg/kg dam
Dose-related skin Irritation; Increase In
urinary coproporphyrln In high-dose males
and slight pallor of liver In males and
females
Rao et al.. 1982
1.2.3-TCB - 1.2.3-trlchlorobenzene; 1.2.4-TCB . 1.2.4-trlchlorobenzene; 1.3.5-TCB = 1.3.5-trtchlorobenzene
is*
tn
CD
in
-------
porphyMn was Increased In rats exposed to 1,2,4-trlchlorobenzene at 223 or
742 mg/m3, which the Investigators Interpreted as a compound-specific
physiologic effect rather than a toxic effect. A follow-up study supported
this Interpretation. The same Investigators exposed male and female
Sprague-Dawley rats to 1,2,4-tMchlorobenzene at 0, 22.3 mg/m3 (3 ppm) or
74.2 mg/m3 (10 ppm) for 6 hours/day, 5 days/week for 3 months. The
results, which were reported In an abstract (Watanabe et al., 1978).
Indicated that urinary excretion of porphyrlns was slightly Increased 1n the
74.2 mg/m3 group during exposure, but returned to control range 2-4 months
postexposure. Since this appeared to be the most sensitive Indicator In
rats, and exposure to trlchlorobenzene at 22.3 mg/m3 did not cause
Increased porphyrln excretion, 22.3 mg/m3 was considered a no-observed-
adverse-effect level (NOAEL) for rats by the authors.
Sasmore et al. (1983) exposed male and female outbred albino CD rats
(20/group) to 1,3,5-trlchlorobenzene vapor at 0, 10, 100 or 1000 mg/m3 for
6 hours/day, 5 days/week for up to 13 weeks. No significant effects were
observed on body weights, food consumption, standard hematologlc and clini-
cal chemistry parameters or on methemoglobin and porphyrln levels. In a
subgroup of five animals/sex/group killed after 4 weeks of exposure, the
only altered experimental parameter was an Increase 1n the llver-to-body
weight ratios In the male 1000 mg/m3 group, but this effect was not
observed at 13 weeks. Since gross and microscopic pathologic examinations
of the liver revealed no treatment-related abnormalities, the authors
concluded that the exposure did not cause hepatotoxldty. Microscopic
examinations, however, revealed that three high-dose rats had squamous
metaplasia and focal hyperplasla of the respiratory epithelium, which the
authors believed to be reversible.
03760 V-9 04/05/91
-------
Coate et al. (1977) exposed groups of 30 male Sprague-Dawley rats, 16
male New Zealand rabbits and 9 male monkeys (Hacaca fasclcularls) to 99.07%
pure 1,2,4-trlchlorobenzene vapor at levels of 0, 186 mg/m3 (25 ppm), 371
mg/m3 (50 ppm) or 742 mg/m3 (100 ppm) for 7 hours/day, 5 days/week for
26 weeks. Pulmonary function and operant behavior tests In the monkeys.
ophthalmic examinations In the rabbits and monkeys, and measurements of body
weight, hematologlc Indices and serum biochemistry parameters In all species
were conducted before and during the exposure period. Subgroups of 5 rats
each were killed after 4 and 13 weeks of exposure; all remaining rats were
killed after 26 weeks for hlstologlc examination of selected tissues. No
treatment-related effects at any observation time were seen with respect to
body weight, survival, hematology or serum chemistry for any of the
species. No ophthalmic changes were observed In rabbits or monkeys. Pul-
monary function and operant behavior were unaffected In monkeys. Hlstologlc
examination of rat tissues revealed that treated animals had enlarged
hepatocytes that were more prominent at 4 weeks than at 13 weeks after expo-
sure, and at 371 and 742 mg/m3 than at 186 mg/m3. Other changes In
treated rats that did not appear to be dose-dependent were vacuollzatlon of
hepatocytes at 4 and 13 weeks, slightly more severe granuloma of the liver
at 4 weeks and biliary hyperplasla at 4 and 13 weeks. A nondose-related In-
crease In the severity of kidney hyaline degeneration was observed In test
rats at 4 weeks. This lesion was slightly more severe In the high-dose
group at 13 weeks. These effects appeared to be transient; rats necropsled
after 26 weeks of exposure had none of these changes. Likewise, hlstologlc
examination of selected tissues from rabbits and monkeys revealed no
treatment-related changes after 26 weeks of exposure.
03760 V-10 04/05/91
-------
Carlson and Tardlff (1976) assessed the effects of 14- or 90-day oral
administration of 1,2,4-tMchlorobenzene 1n corn oil compared with corn oil
controls 1n male CO rats. In the 14-day studies, the effects examined were
lethality, hepatotoxlclty and the Influence on hexabarbltal sleeping time
and other parameters of xenoblotlc metabolism. A dose of 600 mg/kg/day, the
highest dose administered, caused no deaths during the 14-day administration
period. Hepatotoxlclty was evaluated by dosing at 0, 150, 300 or 600
mg/kg/day and determining serum Isodtrate dehydrogenase and liver glucose-
6-phosphatase activities. Although no dose-related changes In serum Iso-
dtrate dehydrogenase activity was observed, liver glucose-6-phosphatase
activity was significantly decreased at >300 mg/kg (p<0.05). Hexabarbltal
sleeping time was significantly decreased at 600 mg/kg/day (the only dose
examined); this effect persisted through a 14-day recovery period. In rats
receiving 14 dally doses at 0, 10, 20 or 40 mg/kg, there was a significant
dose-related Increase In llver-to-body weight ratio at >10 mg/kg/day
(p<0.05). Significant dose-related Increases were also observed 1n activi-
ties or contents of cytochrome c reductase (at >10 mg/kg), cytochrome P-450
(at >20 mg/kg), glucuronyltransferase (at >20 mg/kg), azoreductase (at >10
mg/kg) and the rate of detoxlcatlon of EPN (at >10 mg/kg). These results
Indicated that the doses, while causing a slight degree of hepatic Injury,
significantly enhanced xenoblotlc metabolism.
In the 90-day studies by Carlson and Tardlff (1976), the effects of oral
dosing of male CD rats (6 animals/group) at 0, 10, 20 or 40 mg/kg/day with
1.2,4-trlchlorobenzene 1n corn oil on weight gain, liver weight, hemoglobin
content, packed cell volume and the Indicators of xenoblotlc metabolism were
evaluated. No effects on weight gain and no consistent alteration In hemo-
globin content or packed cell volume were observed. At 40 mg/kg, there was
03760 V-ll 09/24/85
-------
a statistically significant Increase (p<0.05) 1n llver-to-body weight ratios
that persisted throughout a 30-day recovery period. Following 90-day admin-
istration, cytochrome c reductase activity was Increased at >10 mg/kg, with
recovery after 30 days; cytochrome P-450 levels Increased at >20 mg/kg, fol-
lowed by recovery; glucuronyltransferase activity decreased at >10 mg/kg;
EPN detoxlcatlon Increased at >20 mg/kg; benzopyrene hydroxylase activity
Increased 2-fold at 40 mg/kg; and azoreductase activity Increased at >10
mg/kg.
Groups of 5 female rats (strain not reported) received dally oral doses
of 0, 50, 100 or 200 mg 1,2,4-trlchlorobenzene/kg/day 1n corn oil for 30,
60, 90 or 120 days (Carlson, 1977b). Significant Increases were observed 1n
liver porphyrlns at >100 mg/kg after 30 days exposure and 1n urinary
porphyrlns at 200 mg/kg after 30 days. For the 30-day study, slight but
significant Increases were also observed 1n liver weights at 200 mg/kg.
When the compound was administered for 60 days, only the liver weights were
Increased. The administration of 1,2,4-tMchlorobenzene for 90 days
resulted 1n slight but significant Increases 1n liver weights at >50 mg/kg,
In liver porphyrlns at >100 mg/kg and 1n urine porphyrlns at 200 mg/kg. A
significant Increase was observed for liver porphyrlns when the compound was
given at >50 mg/kg for 120 days. The excretion of 6-am1nolevul1n1c add
and porphoblUnogen In the urine was not Increased at any dose given for any
duration. When the author compared the 1,2,4-trlchlorobenzene results with
the results for hexachlorobenzene, he concluded that the tMchlorobenzene
Induced porphyMa was very small compared with the hexachlorobenzene Induced
porphyrla (Carlson, 1977b).
03760 V-12 09/24/85
-------
A 90-day oral study by Smith et al. (1978), reported In an abstract, was
reviewed by U.S. EPA (1980), who gave further details of the study after
communication with the authors. Rhesus monkeys (4/group) were given 1,2,4-
trlchlorobenzene In dally oral doses of 1, 5, 25, 90, 125 or 173.6 mg/kg.
No toxic effects were observed at <25 mg/kg, while doses of >90 mg/kg were
observed to be toxic, and the 173.6 mg/kg dose was lethal within 20-30 days.
There were no deaths observed In the 1, 5 and 25 mg/kg groups; one death
occurred In each of the 90 mg/kg and 125 mg/kg groups and two deaths
occurred In the 173.6 mg/kg group. Animals on the highest dose exhibited
severe weight loss and predeath fine tremors. All of the animals In the
highest dose group had elevated BUN, Naf. K*. CPK, SGOT, SGPT. LDH and
alkaline phosphatase as well as hypercalcemla and hyperphosphatemla from 30
days on. Smith et al. (1978) have been using the urinary pattern of chlor-
guanlde metabolites as an Indication of cytochrome P-450 dependent drug
metabolism. At the high doses, monkeys showed evidence of the hepatic
Induction as well as Increased clearance of l.v. doses of labeled 1,2,4-trl-
chlorobenzene. Further Information on the study (U.S. EPA, 1980) gave
evidence of liver enzyme Induction In the 90, 125 and 173.6 mg/kg animals.
There were some pathologic changes noted In the livers of the high-dose
groups, primarily a fatty Infiltration. The point at which there was no
effect related to the compound was at the 5 mg/kg level. Since only an
abstract of this study was available and since the Interpretation of this
study was complicated by the use of other drugs and weight losses In the
control animals, a valid no-observed-effect level (NOEL) cannot be derived
from these data.
03760 V-13 04/05/91
-------
Two subchronlc studies have assessed the dermal toxlclty of the tMchlo-
robenzenes. Powers et al. (1975) applied technical grade 1,2,4-trlchloro-
benzene at concentrations of 5 or 25% In petroleum ether, or 100% l,2,4-tr1-
chlorobenzene topically 1n 0.2 ma volumes to the ventral surface of the
ears of New Zealand rabbits (groups of 12 each), 3 times weekly for 13
weeks; a control group received petroleum ether only. Rabbits exposed to 5%
trlchlorobenzene and controls had slight redness and scaling. Dermal
responses at 25 and 100% of the compound Included slight to severe erythema,
severe scaling, desquamatlon, encrustation, and some hair loss and scarring.
The responses were characterized by acanthosls and keratosls, typical of
moderate to severe Irritation and probably attributable to degreaslng
(defattlng) action. No overt signs of systemic toxlclty were noted, body
weight gain was comparable 1n all groups, and none of the animals showed
meaningful changes In gross pathology. The Investigators noted that this
contrasted with the findings of Brown et al. (1969), who reported that some
guinea pigs, exposed topically to 1,2,4-tMchlorobenzene at 0.5 ml/day, 5
days/ week for 3 weeks, died following extensor convulsions and their livers
showed necrotlc foci. This difference 1n results may be attributed to the
site of application (Brown et al., 1969. used the dorsal mldllne for appli-
cation, a more extensive exposure site), the volume applied (0.5 ml vs.
0.2 ma), the species used, and the more frequent (5 times/week vs. 3
times/ week) application, although the total number of exposures was less
(5x3 weeks vs. 3x13 weeks).
Rao et al. (1982) applied technical grade trlchlorobenzene [1,2,4- (70%)
and 1,2,3-tMchlorobenzene (30%)] 5 days/week for 4 weeks, at doses of 0,
30, 150 or 450 mg/kg/day, to the dorsal skin (4x4 Inch area) of groups (5 of
each sex) of New Zealand rabbits weighing ~3 kg. One rabbit died after 18
03760 V-14 09/24/85
-------
applications, but the Investigators were unable to determine the cause of
death by either gross or hlstologlc examination. Gross and hlstologlc
examination of the skin showed evidence of moderate Irritation at the high-
est dose and less Irritation at the lower doses. This Irritation evidence
consisted of epidermal scaling, thickening, fissures, ulcers and erythema.
No treatment-related change was observed In clinical chemistry (BUN, glu-
cose. SGPT, SAP) or hematology. A slight but significant Increase 1n
urinary coproporphyrln was observed In high-dose males (450 mg/kg/day) at
day 24; none was seen In females. This slight porphyrla and a slight gen-
eralized pallor of the liver (3/5 males, 4/4 females) were the only signs of
systemic toxlclty. Extensive hlstologlc examination of numerous tissues
failed to show any treatment-related abnormalities. The volume of tr1-
chlorobenzene applied at the dose levels In this study can be calculated as
=0.06 ml (30 mg/kg). 0.31 ml (150 mg/kg) and 0.93 ml (450 mg/kg) by
multiplying the dose In g/kg by the weight of the rabbits (3 kg) and divid-
ing by the density of trlchlorobenzene (1.45 g/mi).
Chronic Toxldty
No studies on the effects of the tMchlorobenzenes following chronic
oral or Inhalation exposure were available for review; however, a chronic
skin painting study was encountered. Goto et al. (1972) conducted a 6-month
feeding study In mice using hexachlorocyclohexane Isomers and their metabo-
lites. Including 1,2.4-trlchlorobenzene. Male mice (20/group) of the
ICR-JCL strain (age at Initiation 5 weeks, average weight 26.5 g) received a
diet containing 600 ppm of trlchlorobenzene (78 yg of compound/kg body
weight, assuming mice consume 13% of their body weight In food per day).
03760 V-15 08/24/88
-------
The weight gain of treated mice did not differ from controls during the
6-month exposure. At 26 weeks, 10 mice were killed and liver, heart and
kidneys were weighed; no abnormal weight changes were observed. Macroscopic
and hlstologlc examination of the liver revealed no hepatic tumors or any
other lesions.
Yamamoto et al. (1982) studied the toxldty of 1,2,4-tMchlorobenzene
when painted on the skin of Slc:ddy mice 2 times/week for 2 years. Groups
consisted of 75 mice/sex receiving 0.03 ml applications of the compound as
30 or 60% solutions 1n acetone. Controls consisted of 50 mice/sex and
received only acetone. The skin painting produced general symptoms of
excitability and panting, local skin thickening, keratlnlzatlon and Inflam-
mation of the epidermis. These effects were not observed In controls. For
the 30% tHchlorobenzene groups, mortality was Increased In females (5/75
survived for 83 weeks compared with 11/50 controls). The mean survival days
were 357il25.4 for treated females compared with 423.8+145.0 for controls
(p<0.01). The survival of males at this exposure level was not signifi-
cantly different from that of controls. Spleen weights were significantly
Increased (p<0.05) and left adrenal weights were significantly decreased
(p<0.01) for treated males when compared with controls. Hematologlc and
blood chemistry Indices were essentially unchanged with the exception of
decreased red blood cell counts 1n the 30% treated males (p<0.05) and
decreased Cl~ concentration (p<0.01). For the 60% solution, 6/75 treated
females survived for 83 weeks. Mean survival days were 320.2+147.7 for
treated females compared with 423.8+.145.0 for controls (p<0.001). Eight of
75 treated males survived for 83 weeks compared with 9/50 control males.
03760 V-16 09/25/85
-------
Mean survival days were 288.0^173.7 for treated males and 363.9^173.9 for
controls (p<0.05). Significant differences 1n organ weights from control
values were seen In the spleens of males (p<0.01) and the adrenals of
females (p<0.05). Hematologlc and blood biochemistry changes were seen In
Increased lymphocyte counts In treated females (p<0.05), and In Increased
SGOT (p<0.05), SGPT (p<0.001) and BUN (p<0.01) for treated males.
Hutaqenldty
Schoeny et al. (1979) and Lawlor et al. (1979) examined the mutagenlc
potential of 1,2,4-tMchlorobenzene In Salmonella typhlmurlum tester strains
TA98, TA100, TA1535 and TA1537, using the plate Incorporation technique.
Schoeny et al. (1979) used 8 concentrations of trlchlorobenzene ranging from
102 yg/plate to 1.4x10= tig/plate. The toxic dose was determined as
1599 yg/plate (killing of one or more strain on mutagenesls plates).
Trlchlorobenzene was negative for mutagenlcHy In the absence and presence
of S-9 mlcrosomal fractions from unlnduced rats, from rats Induced by the
polychlorlnated blphenyl, Aroclor 1254, and from rats homologously Induced
with trlchlorobenzene.
The study of Lawlor et al. (1979), reported In an abstract, used the
TA1538 strain of S. typhlmurlum 1n addition to the strains previously men-
tioned. Negative results were obtained for five unspecified concentrations
tested 1n the presence and absence of rat liver mlcrosomes Induced by
Aroclor 1254. Because these results were reported 1n an abstract without
the details of the experimental procedures used, the results cannot be crit-
ically evaluated.
03760 V-17 09/25/85
-------
The negative results 1n the Salmonella hlstldlne reversion assay are not
unexpected because this test system Is generally Insensitive to highly
chlorinated compounds (Rlnkus and Legator, 1980).
Carc1nogen1c1ty
Yamamoto et al. (1982) applied 1,2,4-tMchlorobenzene In acetone to the
skin of Slc.ddy mice twice weekly for 2 years. The solution of 1,2,4-tM-
chlorobenzene was 60% for the high dose and 30% for the low dose and the
volume applied was 0.03 mi/application. Each treated group contained 75
animals and there were 50 control animals for each sex. Growth rates In
treated and control mice were comparable through 83 weeks. Mean survival
days were significantly reduced 1n the 60% 1,2,4-trlchlorobenzene groups of
males and females and also 1n the 30X treatment group of females.
Hlstopathology showed some organ sites had Increased non-neoplastlc
lesions. Assuming that all 75 animals 1n the treated groups were examined
and all 50 In the control groups were examined, there would be Increases In
lesions 1n the males In lung, liver, kidney, adrenal, spleen and lymph node
at the high dose, and 1n all of these organs except lymph node In the
females at the high dose. Unfortunately, the English translation of
Japanese text 1s not very specific 1n describing the nature of the lesion
making H difficult to use this Information 1n the Interpretation of the
tumor findings.
No single tumor type was Increased significantly over the control Inci-
dence but among males nine different tumors were found In the high-dose
group as compared with two 1n the low-dose and two 1n the control group.
03760 V-18 09/25/85
-------
In females there were 11 different tumors 1n the high-dose group as compared
with 3 1n the low-dose and 8 In the control group. The authors do not state
whether these tumors were all found In different Individual animals or
whether these were multiple tumors In the same animal. Therefore, the
actual Incidence In terms of the number of tumor bearing animals Is not
known.
Further Information from this study Is necessary for full Interpreta-
tion. This single study 1s clearly Inadequate for making any conclusions
about cardnogenldty 1n humans.
Reproductive and Teratogenlc Toxldty
Studies on the reproductive or teratogenlc effects of tMchlorobenzenes
following Inhalation exposure were not found 1n the available literature.
Robinson et al. (1981) reported a multlgeneratlon study of the reproductive
effects of 1,2,4-tr1chlorobenzene following oral administration. Charles
River rats were continuously exposed to the compound at 0, 25, 100 or 400
ppm 1n drinking water. The authors calculated the dosages for the F~
generation based on water consumption data to be: for females at 29 days of
age, 8.3+0.8, 28.Oil.2, 133.2+.13.4 mg/kg/day, respectively; for males at 29
days of age, 8.5+.0.6, 27.6+1.6, 133.6+_15.6 mg/kg/day, respectively; for
females at 83 days of age. 3.7+.0.1, 14.8+.1.0, S3.6+.3.9 mg/kg/day, respec-
tively; for males at 83 days of age, 2.5+0.1, 8.9+0.3. 33.0+0.4 mg/kg/day,
respectively. The exposure period began with the birth of the F_ genera-
tion and continued through 32 days of age for the F. generation. Each
treatment group consisted of 17-23 Utters. No treatment-related effects
were noted with respect to fertility, neonatal weights, maternal weights,
litter sizes, preweanlng viability or postweanlng growth In any generation.
03760 V-19 09/25/85
-------
Treatment-related differences were seen with respect to food Intake and
water consumption In F. males and females, but they were Inconsistent and
did not occur In other generations. Blood chemistry analyses and locomotor
activity measurements revealed no overt hematologlc or neurologic effects,
and hlstologlc examination of the livers and kidneys of the F, genera-
tion rats revealed no damage. At the 400 ppm dose level, significantly
enlarged adrenals In both sexes of the FQ and F, rats were observed at
95 days of age (p<0.006). A follow-up acute toxlclty study showed-that this
effect could result from three dally l.p. Injections of 500 mg 1,2,4-trl-
chlorobenzene/kg.
Black et al. (1983) reported 1n an abstract a teratogenlclty study 1n
pregnant Wlstar rats using 1,2,4-, 1,2,3- or 1,3,5-trlchlorobenzene adminis-
tered by gavage In doses of 75-600 mg/kg on days 6-15 of gestation (gesta-
tlonal day 0 or 1 not defined). Upon necropsy (gestatlonal day not speci-
fied), thyroid and liver lesions and reduced hemoglobin and hematocrlt
values were observed In treated dams (doses not specified). No teratogenlc
effects were observed In the pups; however, pups exposed to the 1,2,4- and
1.3,5- Isomers (doses not specified) had mild osteogenlc changes.
Kltchln and Ebron (1983) conducted a maternal hepatic toxlclty and
embryotoxlclty study where they administered 1,2,4-trlchlorobenzene (>99%
pure) dissolved 1n corn oil (2 ml/kg) orally to pregnant Sprague-Dawley
(CD strain) rats (6 or more/group) on days 9-13 of gestation and the dams
were then sacrificed on day 14 of gestation. The dosing groups were 0 (corn
oil only). 36. 120. 360 and 1200 mg/kg/day 1,2,4-trlchlorobenzene. All the
dams 1n the 1200 mg/kg/day group died by the third day of dosing. The 360
03760 V-20 04/05/91
-------
mg/kg/day group were observed with a maternal mortality rate of 22% and
greatly reduced body weight gains. Maternal liver weights, I1ver-to-body
weight ratios and hepatic mlcrosomal protein content were not affected by
1.2,4-trlchlorobenzene administration. 1,2,4-Tr1chlorobenzene was observed
to be a strong Inducer of hepatic enzymes at the 120 and 360 mg/kg/day dose
levels. Liver histology In the pregnant dams was unremarkable 1n the 36
mg/kg/day group, showed a slight degree of hepatocellular hypertrophy 1n 1
of 9 rats 1n the 120 mg/kg/day group and showed a moderate hepatocellular
hypertrophy 1n 7 of B rats 1n the 360 mg/kg/day group. The uteri from only
the 0 and 360 mg/kg/day groups were examined for 1,2,4-tr1chlorobenzene-
Induced embryonic effects. No statistically significant differences In
resorptlon, embryolethallty or abnormalities were reported, although 3/12
treated Utters showed embryolethallty as compared with 0/12 In the control
litters. Several embryonic parameters were significantly decreased by
1,2,4-trlchlorobenzene treatment. These parameters were embryonic head
length, crown-rump length, somite number and total embryo protein content
(reduced 23X).
Summary
The effects 1n mammals of acute exposure by various routes to trlchloro-
benzenes Include local Irritation, convulsions and death. Livers, kidneys,
adrenals, mucous membranes and brain ganglion cells appear to be target
organs with effects Including edema, necrosis, fatty Infiltration of livers,
Increased organ weights, porphyrln Induction and mlcrosomal enzyme Induction.
03760 V-21 09/25/85
-------
Quantitative data on the toxic effects of trlchlorobenzene following
subchronlc exposure by various routes were obtained In a variety of species.
In general, these studies Indicate that the liver and kidney are target
organs. Inhalation of 1,2,4-trlchlorobenzene at >74.2 mg/m3 (10 ppm) for
6 hours/day, 5 days/week for up to 26 weeks Induced hepatocytomegaly and
hyaline degeneration In several species (Koclba et al., 1981; Watanabe et
al., 1978; Coate et al., 1977), although these effects may be to some extent
reversible. One study (Watanabe et al., 1978) Identified 22.3 mg/m3 (3
ppm) as a NOAEL In rats. Sasmore et al. (1983) reported that some rats
exposed by Inhalation to 1,3,5-tMchlorobenzene at 1000 mg/m3 for 13 weeks
showed squamous metaplasia and focal hyperplasla of the respiratory epithe-
lium, which appeared to be reversible. Subchronlc oral studies have also
found that the tMchlorobenzenes Induce hepatic xenoblotlc metabolism
(Carlson and Tardlff, 1976; Smith et al., 1978) and porphyrla (Carlson.
1977b). Subchronlc dermal exposure resulted In mild to moderate Irritation
(Powers et al.. 1975; Rao et al.. 1982).
One chronic study, on the effects of trlchlorobenzene painted on the
skin of mice for 2 years, reported Increased mortality In females at the low
dose (30X solution In acetone) and In both sexes at the high dose (60X solu-
tion) (Yamamoto et al.. 1982). While numbers of all tumor types appeared to
be Increased, no significant change was detected for any Individual tumor
type. Thus, the carcinogenic results from the only relevant study are
considered Inconclusive.
Results of two reports on mutagenlclty tests with Salmonella typhlmurlum
test strains were negative (Schoeny et al., 1979; Lawlor et al., 1979).
However, this test system Is generally Insensitive to chlorinated compounds.
03760 V-22 08/18/87
-------
A multlgeneratlon study of -the reproductive effects of oral exposure to trl-
chlorobenzene (Robinson et al., 1981) failed to show effects on reproduc-
tion. TeratogenlcUy studies after administration by the oral route 1n rats
{Black et al.. 1983; KHchln and Ebron, 1983) showed mild osteogenlc changes
In pups and significantly retarded embryonic development as measured by
growth parameters.
03760 V-23 09/25/85
-------
VI. HEALTH EFFECTS IN HUMANS
Information on the health effects of tMchlorobenzenes In humans Is
limited to case reports. Rowe (1975) found that an Individual exposed to
1,2,4-tMchlorobenzene at 3-5 ppm had eye and respiratory Irritation.
Glrard et al. (1969) reported two cases, one In which a 68-year-old woman,
who often soaked her husband's work clothes In trlchlorobenzene, developed
aplastlc anemia, and the other In which a 60-year-old man, who had been
occupatlonally exposed to DDT as well as to mono-. d1- and trlchlorobenzenes
for over 30 years, developed anemia.
Summary
Limited data are available on human exposure to trlchlorobenzenes. No
conclusions can be drawn from this data.
03770 VI-1 09/12/88
-------
VII. MECHANISMS OF TOXICITY
Several studies discussed 1n Chapter V on acute toxlclty have demon-
strated that the Isomers of trlchlorobenzene are capable of affecting xeno-
blotlc metabolism by Inducing a variety of the hepatic drug-metabolizing
enzymes In rats. These Include cytochrome c reductase, cytochrome P-450,
glucuronyltransferase, benzopyrene hydroxylase, azoreductase (Carlson and
Tardlff. 1976; Carlson. 1977a, 1978. 1981; Smith and Carlson, 1980; Denomme
et al., 1983). acetanlUde esterase and acetanlUde hydroxylase, procalne
esterase (Carlson et al.. 1979). arylesterase (Carlson. 1980). mlcrosomal
proteins, phosphollplds and amlnopyrene hydroxylase (Arlyoshl et al.,
1975a,b.c). That tMchlorobenzenes enhance xenoblotlc metabolism has been
demonstrated by Smith and Carlson (1980) and Carlson (1977a), who showed
that administration of 1,2,4- or 1,3,5-tMchlorobenzene to groups of 4 male
Sprague-Dawley rats for 7 days Increased EPN detoxlcatlon. The administra-
tion of 1,2,4-trlchlorobenzene to pregnant rats was also reported to Induce
hepatic levels of cytochrome P-450, cytochrome c reductase, UOP glucuronyl-
transferase and glutathlone S-transferase (Kltchln and Ebron. 1983).
Townsend and Carlson (1981) demonstrated that 1,2,4-trlchlorobenzene,
administered by gavage 1n corn oil to groups of five male Swiss mice at
181.5 mg/kg (1 mmol/kg) for 7 days, Increased the LD5Q and protected the
mice against the toxic effects of malathlon, malaoxon, parathlon and para-
oxon when graded doses of these Insecticides were administered on the day
following the last dose of trlchlorobenzene.
03780 VII-1 09/24/85
-------
Experiments comparing the effects of trlchlorobenzenes with the effects
of phenobarbUal and 3-methylcholanthrene Indicated that the Inductions of
mlcrosomal enzymes by trlchlorobenzenes are of the phenobarbltal type
(Carlson, 1978).
These data suggest that the trlchlorobenzenes stimulate the drug metabo-
lizing enzyme system In animals. Thus, these compounds would be expected to
Increase the rate of their own metabolism, particularly with multiple expo-
sures, resulting In Increased production of reactive Intermediates and
potentially a greater toxic response.
The series of studies by AMyoshl (1975a,b,c) demonstrated that trl-
chlorobenzenes stimulated the activity of i-am1nolevu!1n1c add synthe-
tase. Since this enzyme Is the rate-limiting step 1n heme synthesis Us
elevated activity would be expected to result In the production of elevated
levels of heme precursors. This may well account for at least part of the
Increased urinary excretion of coproporphyrln, porphoblUnogen and uropor-
phyrln In rats treated with trlchlorobenzenes as reported by Rlmlngton and
Zlegler (1963). These authors also reported elevated levels of these heme
precursors 1n the livers of treated rats.
There are some Indications 1n the report of Powers et al. (1975) that
the Irritant effects noted In skin may be, at least partially, related to
the defattlng action of the trlchlorobenzenes.
03780 VII-2 04/12/91
-------
Summary
The mechanism of toxlclty for trlchlorobenzene 1s not completely known.
The cllnUal effects of porphyMa are sometimes observed In animals and
humans exposed to trlchlorobenzene, but to a lesser extent than for
hexachlorobenzene. The capacity of trlchlorobenzene to stimulate the
activity of i-am1nolevul1n1c acid synthetase Is well documented. Since
this enzyme 1s the rate-limiting step In heme synthesis, there Is a direct
link to excess porphyrln production.
03780 VII-3 04/30/91
-------
VIII. QUANTIFICATION OF TOXICOLOGIC EFFECTS
Introduction
The quantification of toxlcologlc effects of a chemical consists of
separate assessments of noncarclnogenlc and carcinogenic health effects.
Chemicals that do not produce carcinogenic effects are believed to have a
threshold dose below which no adverse, noncarclnogenlc health effects occur,
while carcinogens are assumed to act without a threshold.
In the quantification of noncarclnogenlc effects, a Reference Dose
(RfD), [formerly termed the Acceptable Dally Intake (ADI)] 1s calculated.
The RfD Is an estimate (with uncertainty spanning perhaps an order magni-
tude) of a dally exposure to the human population (Including sensitive
subgroups) that 1s likely to be without an appreciable risk of deleterious
health effects during a lifetime. The RfD Is derived from a no-observed-
adverse-effect level (NOAEL), or lowest-observed-adverse-effect level
(LOAEL), Identified from a subchronlc or chronic study, and divided by an
uncertainty factor(s) times a modifying factor. The RfD Is calculated as
follows:
Dfn (NOAEL or LOAEL) .. . ..
RfD = * ' = mg/kg bw/day
[Uncertainty Factor(s) x Modifying Factor] y * 3
Selection of the uncertainty factor to be employed In the calculation of
the RfD Is based upon professional judgment, while considering the entire
data base of toxlcologlc effects for the chemical. In order to ensure that
uncertainty factors are selected and applied In a consistent manner, the
03790 VIII-1 04/05/91
-------
U.S. EPA (1991) employs a modification to the guidelines proposed by the
National Academy of Sciences (NAS, 1977, 1980) as follows:
Standard Uncertainty Factors (UFs)
Use a 10-fold factor when extrapolating from valid experimental
results from studies using prolonged exposure to average healthy
humans. This factor Is Intended to account for the variation
In sensitivity among the members of the human population. [10H]
Use an additional 10-fold factor when extrapolating from valid
results of long-term studies on experimental animals when
results of studies of human exposure are not available or are
Inadequate. This factor Is Intended to account for the uncer-
tainty In extrapolating animal data to the case of humans.
[10A]
Use an additional 10-fold factor when extrapolating from less
than chronic results on experimental animals when there Is no
useful long-term human data. This factor Is Intended to
account for the uncertainty In extrapolating from less than
chronic NOAELs to chronic NOAELs. [10S]
Use an additional 10-fold factor when deriving an RfD from a
LOAEL Instead of a NOAEL. This factor Is Intended to account
for the uncertainty In extrapolating from LOAELs to NOAELs.
[10L]
Modifying Factor (MF)
Use professional judgment to determine another uncertainty
factor (MF) that 1s greater than zero and less than or equal to
10. The magnitude of the MF depends upon the professional
assessment of scientific uncertainties of the study and data
base not explicitly treated above, e.g., the completeness of
the overall data base and the number of species tested. The
default value for the MF 1s 1.
The uncertainty factor used for a specific risk assessment Is based
principally upon scientific judgment rather than scientific fact and
accounts for possible Intra- and Interspedes differences. Additional
considerations not Incorporated In the NAS/ODW guidelines for selection of
an uncertainty factor Include the use of a less than lifetime study for
deriving an RfD, the significance of the adverse health effects and the
counterbalancing of beneficial effects.
03790 VI11-2 04/05/91
-------
From the RfD. a Drinking Water Equivalent Level (DUEL) can be calcu-
lated. The DUEL represents a medium specific (I.e., drinking water)
lifetime exposure at which adverse, noncarclnogenlc health effects are not
anticipated to occur. The DWEL assumes 100% exposure from drinking water.
The DUEL provides the noncarclnogenlc health effects basis for establishing
a drinking water standard. For Ingestlon data, the DUEL Is derived as
follows:
-------
The 1-day HA calculated for a 10 kg child assumes a single acute
exposure to the chemical and 1s generally derived from a study of <7 days
duration. The 10-day HA assumes a limited exposure period of 1-2 weeks and
1s generally derived from a study of <30 days duration. The longer-term HA
1s derived for both the 10 kg child and a 70 kg adult and assumes an
exposure period of -7 years (or 10% of an Individual's lifetime). The
longer-term HA Is generally derived from a study of subchronlc duration
(exposure for 10% of animal's lifetime).
The U.S. EPA categorizes the carcinogenic potential of a chemical, based
on the overall welght-of-evidence, according to the following scheme:
Group A: Human Carcinogen. Sufficient evidence exists from
epidemiology studies to support a causal association between
exposure to the chemical and human cancer.
Group B: Probable Human Carcinogen. Sufficient evidence of
carclnogenlclty In animals with limited (Group Bl) or Inade-
quate (Group B2) evidence In humans.
Group C: Possible Human Carcinogen. Limited evidence of
carclnogenlclty 1n animals 1n the absence of human data.
Group D: Not Classified as to Human Carclnogenlclty. Inade-
quate human and animal evidence of carclnogenlclty or for which
no data are available.
Group E: Evidence of Noncarclnogenlclty for Humans. No
evidence of carclnogenlclty In at least two adequate animal
tests In different species or In both adequate epldemlologlc
and animal studies.
If toxlcologlc evidence leads to the classification of the contaminant
as a known, probable or possible human carcinogen, mathematical models are
used to calculate the estimated excess cancer risk associated with the
Ingestlon of the contaminant 1n drinking water. The data used In these
03790 VIII-4 04/05/91
-------
estimates usually come from lifetime exposure studies using animals. In
order to predict the risk for humans from animal data, animal doses must be
converted to equivalent human doses. This conversion Includes correction
for noncontlnuous exposure, less than lifetime studies and for differences
1n size. The factor that compensates for the size difference Is the cube
root of the ratio of the animal and human body weights. It Is assumed that
the average adult human body weight Is 70 kg and that the average water
consumption of an adult human 1s 2 a of water per day.
For contaminants with a carcinogenic potential, chemical levels are
correlated with a carcinogenic risk estimate by employing a cancer potency
(unit risk) value together with the assumption for lifetime exposure from
Ingest Ion of water. The cancer unit risk Is usually derived from a linear-
ized multistage model with a 95% upper confidence limit providing a low dose
estimate; that Is, the true risk to humans, while not Identifiable, Is not
likely to exceed the upper limit estimate and, In fact, may be lower.
Excess cancer risk estimates may also be calculated using other models such
as the one-hit, Welbull. logH and problt. There Is little basis In the
current understanding of the biologic mechanisms Involved In cancer to
suggest that any one of these models Is able to predict risk more accurately
than any other. Because each model 1s based upon differing assumptions, the
estimates derived for each model can differ by several orders of magnitude.
The scientific data base used to calculate and support the setting of
cancer risk rate levels has an Inherent uncertainty that Is due to the
systematic and random errors In scientific measurement. In most cases, only
studies using experimental animals have been performed. Thus, there Is
03790 VIII-5 04/05/91
-------
uncertainty when the data are extrapolated to humans. When developing
cancer risk rate levels, several other areas of uncertainty exist, such as
the Incomplete knowledge concerning the health effects of contaminants In
drinking water, the Impact of the experimental animal's age, sex and
species, the nature of the target organ system(s) examined and the actual
rate of exposure of the Internal targets In experimental animals or humans.
Dose-response data usually are available only for high levels of exposure
and. not for the lower levels of exposure closer to where a standard may be
set. When there Is exposure to more than one contaminant, additional
uncertainty results from a lack of Information about possible synerglstlc or
antagonistic effects.
Noncardnogenlc Effects
A number of biologic endpolnts have been Identified In short-term
studies with 1,2,4-TCB Including transient porphyrta, transient hepatic
cellular changes, and Increase 1n adrenal gland weight and reproductive
effects (Coate et al., 1977; Koclba, 1981; KUchln and Ebron, 1983; Robinson
et al., 1981). In a reproductive study In rats, 25, 100 or 400 ppm of
1,2,4-trlchlorobenzene, administered to the parental animals In their
drinking water, produced no reproductive, hematologlc or neurologic effects
(Robinson et al., 1981). Increased adrenal gland weight occurred In both
the parents and offspring at the highest dose level. This change was found
to be associated with vacuollzatlon of the zona fasdculata of the adrenal
cortex and decreased serum cortlcosterone levels (dcmanec, 1991). Retarded
embryonic development was observed 1n pregnant rats receiving
1,2,4-trlchlorobenzene 360 mg/kg/day on days 9-13 of gestation (K1tch1n and
Ebron, 1983).
03790 VIII-6 01/03/92
-------
Hepatic porphyMa, porphyrlnurla and hepatic cellular changes have been
observed following the administration of 1,2,4-tMchlorobenzene but these
changes either occurred at very high doses or were transient. Coate et al.
(1977) reported a study 1n rats, rabbits and cynomolgus monkeys (Hacaca
fasclcularls) that Involved Inhalation exposure for 26 weeks. In rats
hepatocytomegaly, hepatic vacuollzatlon and biliary hyperplasla were seen at
4 weeks and 13 weeks but not at the completion of the study. No significant
changes were seen 1n the rabbits or monkeys. Carlson (1977) reported a
study In rats that Investigated the potential Induction of porphyla by
hexachlorobenzene, trlchlorobenzene and dlchlorobenzene when given by oral
gavage at 0, 50, 100 and 200 mg/kg/day. Only hexachlorobenzene showed a
marked ability to Induce porphyMa and the author determined that d1- and
trlchlorobenzene did not share this property. In the study reported by
Carlson and Tardlff (1976), male CD rats received 0, 10. 20 and 40 mg/kg/day
and xenoblotlc metabolism was measured as well as body weight and
hematologlc parameters. There was a dose-response related change for all
xenoblotlc enzymes but I1ver-to-body weight ratio was only affected at 40
mg/kg/day.
Koclba et al. (1981) reported a study 1n which male rats, rabbits and
dogs were exposed to 0, 30 or 100 ppm (0, 223 or 742 mg/m3) of
1,2,4-tMchlorobenzene for 44 days. No significant effects were observed
for body weight gain, hematologlc parameters, serum biochemical tests or
microscopic appearance of tissues. A reversible Increase 1n urinary
porphyrlns was noted but the authors Interpreted this change as being a
compound-specific physiologic effect rather than a sign of toxlclty. In a
2-year mouse skin painting study (Yamamoto et al., 1982) a slight Increase
03790 VIII-7 01/03/92
-------
1n tumors of all sites was reported, but no conclusions can be drawn about
carclnogenldty because of the lack of details In the English translation of
the text.
Quantification of Noncardnoqenlc Effects
Table VIII-1 presents a summary of the subchronlc and chronic toxlclty
studies on the tHchlorobenzenes that were considered for calculation of a
DWEL for each trlchlorobenzene. Table VIII-2 presents the toxlclty thresh-
old estimates that were determined from the studies discussed In Chapter V.
As Indicated by these tables and Chapter V, very little toxlclty data are
available to derive credible HAs or DWELs for the 1,2,3- and 1,3,5-tM-
chlorobenzenes Isomers. Therefore, no HAs or DWELs are recommended for
these two trlchlorobenzene Isomers.
Derivation of 1-Dav HA. The acute studies by AMyoshl et al.
(1975a,b,c) were selected for derivation of the 1-day HA for 1.2.4-tM-
chlorobenzene.
In a series of experiments, AMyoshl et al. (1975a,b,c) studied the
effects of the tMchlorobenzenes on Induction of hepatic mlcrosomal pro-
teins, phosphollplds and enzymes, especially In relation to the activity of
4-am1nolevul1n1c acid synthetase, the rate limiting enzyme 1n the biosyn-
thesis of heme. The three trlchlorobenzene Isomers were administered orally
to groups of 2-6 female Ulstar rats at a dose of 250 mg/kg/day for 3 days,
after which the rats were killed and mlcrosomes were prepared. The results
Indicated that trlchlorobenzenes Increased the levels of mlcrosomal
proteins, phosphollplds and cytochrome P-450, and enhanced the activities of
03790 VIII-8 01/03/92
-------
O)
-J
to
o
TABLE VIII-1
Sunmary of Subchronlc and Chronic ToxicIty Studied on Trlchlorobenzenes
Species Route
Rat Inhalation
Rats, rabbits. Inhalation
two dogs
Rat Inhalation
Rat inhalation
Rabbits. Inhalation
murikpys
Monkey oral
Rat oral
Rat oral
House oral
Dose
10. 100 or
1000 ng/n*
of 1,3.5-TCB
223 or 742 ng/n»
of 1,2,4-TCB
22.3 or
74.2 rag/n»
of 1.2.4-TCB
186. 371 or
742 mg/ra»
of 1.2.4-TCB
186. 371 or
742 mg/rn*
of 1.2.4-TCB
1. 5. 25. 90.
12S or 173.6
mg/kg/day
of 1.P.4-TCB
50. 100 or
200 mg/kg/day
of 1.2.4-TCB
10. 20 or
40 mg/kg/day
of 1.2.4-TCB
600 ppm diet
(00/8 mg/kg/
day) of
!.?.« ICB
Duration
6 hours/day.
5 days/week for
up to 13 weeks
7 hours/day.
5 days/week; total
of 30 exposures In
44 days
6 hours/day,
5 days/week.
3 months
7 hours/day.
5 days /week,
26 weeks
7 hours/day.
5 days /week.
26 weeks
30 days
30. 60. 90 or
120 days
90 days
6 months
Effects Reference
No hepatotoxlclty; three high-dose rats had Sasmore et al., I9B3
squamous metaplasia and focal hyperplasta
of respiratory epithelium, believed to be
reversible
Increase In urinary excretion of porphyrla Koclba et al.. 1981
In exposed rats; Increase In liver weights
In high-dose rats and dogs; Increased kid-
ney weights In high-dose rats
Increase In urinary porphyrln excretion In Watanabe et al.. 1978
high-dose rats; no effects In 22.3 mg/m'
group
Enlarged hepatocytes and nondose-dependent Coate et al.. 1977
hepatocytes vacuoltzatlon. liver granuloma.
biliary hyperplasla and kidney hyaline de-
generation at 4 and 13 wk; no hlstopathology
evident at 26 wk
No treatment related changes at 26 wk Coate et al.. 1977
<25 mg/kg/day - no effects observed; Smith et al.. 1978
T25 mg/kg/day - observed toxic Ity and death
Increases In liver weights, liver porphyrlns Carlson. 1977b
and urine porphyrlns. dose and time related
Increase In llver-to-body weight ratio In Carlson and lardllf.
high-dose group; changes In enzyme actlva- 1976
lion at al 1 doses
No effects Goto et dl . 197?
-------
TABLE VIII-1 (cont.)
u>
o
I
o
Species
Guinea pig
Mouse
Rats
Rats
Rabbits
Route Dose
dermal 0.5 ml/day
of 1.2.4-TCB
dermal 0.03 mt /paint-
ing of 30 and
60Jt solution In
acetone of
1.2.4-TCB
oral 25. 100 or
(drinking 400 mg/l
water) of 1.2.4-TCB
oral 36. 120. 360 or
1200 mg/kg/day
of 1.2.4-TCB
dermal 30. 150 or
450 mg/kg/day
of 1.2.3-TCB
(30X) and
1.2,4-TCB (70X)
Duration
5 days/week.
3 weeks
2 times/week,
2 years
F0 to F2
generations
days 9-13 of
gestation
5 days/week,
4 weeks
Effects
Death following extensor convulsion; livers
showed necrotlc foci
Painting Induced excitability, panting and
epidermal thickening. Inflammation and
fceratlnlzatlon; Increased organ weights and
mortality
Increased adrenal weight 1n FQ and F|
generations
1200 mg/kg dose all dead by the 3rd day.
360 mg/kg dose caused 22X mortality In
dams and moderate hepatocellular hyper-
trophy and non-slqnlf leant Increases In
embryonic lethality and significantly
retarded embryonic development. 36 and
120 mg/kg groups not observed for embryonic
effects, but slight hepatocellular hyper-
trophy was reported In one 120 mg/kg dam
Dose-related skin Irritation; Increase In
urinary coproporphyrtn In high-dose males
and slight pallor of liver In males and
females
Reference
Brown et al.. 1969
Yamamoto et al.. 19B2
Robinson et al.. 1981
Kltchln and Ebron,
1983
Rao et al.. 1982
1.2.3-TCB = 1.2.3-trlchlorobenzene; 1.2,4-TCB = 1.2,4-trlchlorobenzene; 1.3.5-TCB = 1.3,5-trlchlorobeniene
-------
TABLE VI11-2
Toxlclty Data for Threshold Estimates
Compound
1.2.4-Trlchlorobenzene
1,2.4-Trlchlorobenzene
1,3.5-Trlchlorobenzene
1,2.4-Trtchlorobenzene
Species Route
rat Inhalation
rabbit, monkey Inhalation
rat Inhalation
rat oral
Dose
Concentration
22.3 mg/m».
6 hour /day. 5 day/week
742 rag/m».
7 hour/day, 5 day/week
100 mg/m».
6 hour/day, 5 day/week
14.8 mg/kg/day
Dose
Duration
3 months
26 weeks
13 weeks
95 days/generation
2 generations
Effect
Level
NOAEL*
NOEL*
NOAEL*
NOAEL*
Reference
Watanabe el al.
197B
Coate et al..
1977
Sasmore et al..
1983
Robinson et al.
1981
'Estimated toxlclty thresholds as determined In the respective Mammalian Toxlclty Sections of this document.
NOEL - No-observed-effect level: That exposure level at which there are no statistically significant Increases In frequency or severity ol
effects between the exposed population and Its appropriate control.
NOAEL • No-observed-adverse-effect level: That exposure level at which there are no statistically significant Increases In frequency or
severity of adverse effects between the exposed population and Us appropriate control. Effects are produced at this dose, but they are not
considered to be adverse.
IS)
-------
aniline hydroxylase, amlnopyrlne demethylase and 6-am1nolevul1n1c add
synthetase. with the l,2,4-1somer being the most effective (Arlyoshl et al.,
1975a,b). The dose-response of these effects to 1,2,4-trlchlorobenzene were
determined (AMyoshl et al., 1975c) for groups of 2-6 female Wlstar rats
treated orally with single doses of 0, 125, 250, 500, 750, 1000 and 1500
mg/kg. The results Indicated that 24 hours after the administration of the
Isomer, mlcrosomal protein was elevated at >750 mg/kg and glycogen content
was decreased at >500 mg/kg. The activities of amlnopyrlne demethylase and
aniline hydroxylase and the content of cytochrome P-450 were Increased at
>250 mg/kg, as was j-amlnolevullnlc acid synthetase activity. A slight
significant Increase In 6-am1nolevul1n1c add synthetase activity was
observed 1n the 125 mg/kg group with a dose-related Increase In activity In
the higher dose levels. The 125 mg/kg dose can be utilized as a NOAEL for
the 1-day HA calculations.
The 1-day HA for a 10 kg child Is calculated using the 24 hour oral
NOAEL of 125 mg/kg reported by AMyoshl et al. (1975c) as follows.
For a 10 kg child:
i -, ... (125 mq/kq/day x 10 kg) , ... . . . . . ,
1-day HA = J j* * ' ^ =1.25 mg/l (rounded to 1 mg/l)
where:
125 mg/kg/day = NOAEL, based on the absence of adverse effects
In rats (AMyoshl et al., 1975c)
10 kg = assumed body weight of a child
1 a/day = assumed water consumption by a child
1000 = uncertainty factor, 1n accordance with NAS/ODW
and Agency guidelines for use with a NOAEL from
an animal study and to account for limited data.
This HA 1s equivalent to 1 mg/day or 0.1 mg/kg/day.
03790 VIII-12 01/03/92
-------
Derivation of 10-Dav HA. The Carlson and Tardlff (1976) study was
chosen for derivation of the 10-day HA for 1,2,4-trlchlorobenzene.
Carlson and Tardlff (1976) assessed the effects of a 14-day oral admin-
istration of 1,2,4-trlchlorobenzene In corn oil compared with corn oil
controls 1n male CD rats. In the 14-day studies, the effects examined were
lethality, hepatotoxlclty and the Influence on hexabarbltal sleeping time
and other parameters of xenoblotlc metabolism.* A dose of 600 mg/kg/day,
the highest dose administered, caused no deaths during the 14-day
administration period. Hepatotoxlclty was evaluated by dosing at 0, 150,
300 or 600 mg/kg/day and determining serum Isocltrate dehydrogenase and
liver glucose-6-phosphatase activities. Although no dose-related changes In
serum Isocltrate dehydrogenase activity was observed, liver
glucose-6-phosphatase activity was significantly decreased at >300 mg/kg
(p<0.05). Hexabarbltal sleeping time was significantly decreased at 600
mg/kg/day (the only dose examined); this effect persisted through a 14-day
recovery period. In rats receiving 14 dally doses at 0, 10, 20 or 40 mg/kg,
there was a significant dose-related Increase In I1ver-to-body weight ratio
*The stimulation of the xenoblotlc metabolizing system may be considered
primarily a physiologic response, although 1n the case of the
trlchlorobenzenes Increased metabolism of subsequent doses and the
production of reactive Intermediates and phenolic metabolites would be
expected to enhance toxldty. In addition, the elevated activity of
6-am1nolevul1n1c acid synthetase, the rate limiting step In heme
synthesis, at 250 and 125 mg/kg dose levels suggests Increased porphyrln
synthesis. This 1s verified at higher dose levels In other studies where
Increased porphyrln excretion 1n the urine has been documented.
Stimulation of porphyrln synthesis may be seriously detrimental to some
portions of the population. The use of drugs, such as barbiturates, that
enhance porphyrln synthesis are contralndlcated In patients with
Intermittent porphyrla or porphyMa varlegata (Goodman and Oilman, 1985).
Thus, 1n addition to the sparse data, the potential effects of the
stimulation of heme synthesis 1n man warrants an additional safety factor
of 10 1n this calculation.
03790 VIII-13 01/03/92
-------
at >10 mg/kg/day (p<0.05). Significant dose-related Increases were also
observed In activities or contents of cytochrome c reductase (at >10 mg/kg),
cytochrome P-450 (at >20 mg/kg), glucuronyltransferase (at >20 mg/kg),
azoreductase (at >10 mg/kg) and the rate of detoxlcatlon of EPN (at >10
mg/kg). These results Indicated that the doses, while causing a slight
degree of hepatic Injury, significantly enhanced xenoblotlc metabolism. The
dose of 10 mg/kg/day can be considered a NOAEL since none of the effects
observed at this dose can be directly considered adverse but rather adaptive
responses.
The 10-day HA for a 10 kg child Is calculated using the 14-day oral
NOAEL of 10 mg/kg/day reported by Carlson and Tardlff (1976) as follows.
For a 10 kg child:
10-day HA = dO mq/kq/day x lOkq) =
100 x U/day
where:
10 mg/kg/day = NOAEL, based on the absence of adverse effects
In rats (Carlson and Tardlff, 1976)
10 kg = assumed body weight of a child
1 i/day = assumed water consumption by a child
100 = uncertainty factor, 1n accordance with NAS/ODW
and Agency guidelines for use with a NOAEL from
an animal study.
This HA 1s equivalent to 1 mg/day or 0.1 mg/kg/day.
Derivation of Longer-term HA. Three studies were evaluated as the
possible basis for the derivation of longer-term HAs for a 10 kg child or a
70 kg adult. Two of the studies were oral studies (Carlson and Tardlff,
1976; Robinson et al., 1981) and one was an Inhalation study (Kodba et al.,
1981).
03790 VIII-14 12/17/91
-------
In the 90-day study by Carlson and Tardlff (1976), the effects of oral
dosing of male CD rats (6 animals/group) at 0, 10, 20 or 40 mg/kg/day with
1,2,4-trlchlorobenzene In corn oil on weight gain, liver weight, hemoglobin
content, packed cell volume and the Indicators of xenoblotlc metabolism were
evaluated. No effects on weight gain and no consistent alteration In hemo-
globin content or packed cell volume were observed. At 40 mg/kg, there was
a statistically significant Increase (p<0.05) 1n llver-to-body weight ratios
that persisted throughout a 30-day recovery period. Following 90-day admin-
istration, cytochrome c reductase activity was Increased at >10 mg/kg. with
recovery after 30 days; cytochrome P-450 levels Increased at >20 mg/kg,
followed by recovery; glucuronyltransferase activity decreased at >10 mg/kg;
EPN detoxlcatlon Increased at >20 mg/kg; benzopyrene hydroxylase activity
Increased 2-fold at 40 mg/kg; and azoreductase activity Increased at >10
mg/kg.
The Robinson study (1981) was a multlgeneratlon reproductive study In
which dams received 0, 25, 100 or 400 ppm of 1,2,4-trlchlorobenzene (TCB) In
the drinking water. Following birth of the F. generation, Utters of the
F. and FI generations were dosed with 0, 25, 100 or 400 ppm (0, 3.7,
14.8 or 53.6 mg/kg/day) of 1,2,4-trlchlorobenzene for 95 days. Subsequently
these rats were bred and the F. generation received similar dosing.
Seventeen to 23 Utters/dose group were used for the study. During the
study maternal weights, litter size, neonatal sex, and weights were
recorded, as well as food and water Intake. Serum chemistry determinations
for glucose, BUN, creatlnlne, Na, K, Cl. uric acid, CaP, cholesterol,
trlglyceMde, blUrubln, alkaline phosphatase, ALT, AST, LDH, CPK, protein,
globulin and albumin were made. When the rats were killed, organ weights
for liver, kidney, uterus, adrenal glands, lung, heart and gonads were
03790 VIII-15 01/03/92
-------
recorded. The study ended when the F^ generation was 32 days old. A
significant Increase 1n adrenal gland weight (11% for males and 13% for
females) was noted 1n the FQ and F, groups. Further Investigation of
this effect found the adrenal gland Increase to be associated with moderate
vacuollzatlon of the zona fasclculata of the cortex and decreased levels of
cortlcosterone In the 53.6 mg/kg/day level of exposure In male rats
(dcmanec, 1991).
Koclba et al. (1981) reported a study In which male rats, rabbits and
dogs were exposed to 0, 30 or 100 ppm (0, 223 or 742 mg/m3) of
1,2,4-trlchlorobenzene for 44 days. No significant effects were observed
for body weight gain, hematologlc parameters, serum biochemical tests or
microscopic appearance of tissues. A reversible Increase In urinary
porphyrlns was noted but the authors Interpreted this change as being a
compound-specific physiologic effect rather than a sign of toxlclty.
The study by Carlson and Tardlff (1976) used the oral route of exposure,
which 1s preferred for deriving drinking water HAs, but this study was
primarily a study of 1,2,4-tr1chlorobenzene's ability to Induce xenoblotlc
metabolizing enzymes and to alter related parameters such as liver weights.
The critical adverse effect Induced by 1,2,4-trlchlorobenzene of porphyrla
related effects was not evaluated In this study and therefore, makes this
study Inappropriate for deriving HAs.
The longer-term HAs for a 10 kg child and a 70 kg adult are calculated
on the basis of a NOAEL of 14.8 mg/kg/day as established In the Robinson
study.
03790 VIII-16 12/17/91
-------
The longer-term HA for a 10 kg child 1s calculated as follows:
Longer-tern, HA B l".6 ..q/kq/day) « 10 Kq
1 I/day x 100
(rounded to 1 mg/8.)
where:
14.8 mg/kg/day = NOAEL, based on the absence of adverse effects
1n rats (Robinson et al., 1981)
10 kg = assumed body weight of a child
1 l/day = assumed water consumption by a child
100 = uncertainty factor, In accordance with NAS/ODW
and Agency guidelines for use with a NOAEL from
an animal study.
The longer-term HA for a 70 kg adult 1s calculated as follows:
„. (14.8 mg/kq/dav) x 70 kg
Longer-term HA =" = 5.18 mg/i
2 I/day x 100
(rounded to 5 mg/i)
where:
14.8 mg/kg/day = NOAEL, based on the absence of adverse effects
In rats (Robinson et al.. 1981)
70 kg = assumed body weight of an adult
2 i/day = assumed water consumption by an adult
100 = uncertainty factor. In accordance with NAS/ODW
and Agency guidelines for use with a NOAEL
from an animal study.
Assessment of Lifetime Exposure and Derivation of a DWEL. As dis-
cussed In the longer-term HA section the Robinson et al. (1981) study Is the
most appropriate to derive a lifetime DUEL. The lifetime DWEL for a 70 kg
adult 1s calculated as follows.
Step 1 - RfD Derivation
RfD =14'8lmQqo/0kq/daY = 0.0148 mg/kg/day (rounded to 0.01 mg/kg/day)
03790 VIII-17 01/03/92
-------
where:
14.8 mg/kg/day = NOAEL, based on the absence of adverse effects
1n rats (Robinson et al., 1981)
1000 = uncertainty factor. In accordance with NAS/ODW
and Agency guidelines for use with a NOAEL from
a subchronlc animal study.
Step 2 - DUEL Derivation
0.01 mg/kq/dav x 70 kg
DWEL = * =0.35 mg/l
2 I/day
(rounded to 0.4 mg/i)
where:
0.01 mg/kg/day = RfD
70 kg = assumed body weight of an adult
2 l/day = assumed water consumption by an adult
Carcinogenic Effects
One study reported by Yamamato et al. (1982), where 30% or 60% solutions
of 1,2.4-tMchlorobenzene 1n acetone were applied to the skin of Slc.ddy
mice twice weekly for 2 years, was evaluated by the Human Health Assessment
Group (HHAG) of the U.S. EPA. The HHAG evaluation of this study determined
that Insufficient Information was presented 1n this study to allow an
acceptable Interpretation of the data to be made. Also, this single study
was found to be clearly Inadequate for making any conclusions about
carclnogenldty .In humans. Therefore, the trlchlorobenzenes are classified
as U.S. EPA Group D compounds (U.S. EPA, 1991).
Existing Guidelines. Recommendations and Standards
Occupational. There are no U.S. workplace standards for the
trlchlorobenzenes.
03790 VIII-18 01/03/92
-------
The ACGIH has recommended a celling of 5 ppm (40 mg/m3) for
1,2,4-trlchlorobenzene (ACGIH, 1982), and NIOSH classified 1t as a Group III
pesticide. Group III pesticides are less toxic than Group II pesticides and
the recommended criteria for workplace standards are less stringent than
those recommended for Group II pesticides (NIOSH. 1978). The British
Journal of Industrial Medicine reported a provisional operational limit of
25 ppm for 1,2,4-trlchlorobenzene (Verschueren, 1977). The 1971 TLV for
1,2,3-trlchlorobenzene Is 1.3 ppm [10 mg/m3 (n.s.1.)] for the USSR
(Verschueren, 1977).
Trlchlorobenzenes have been designated by the ITC as TSCA Section 4(e)
priority chemicals (44 FR 70666). Preliminary Assessment Information Manu-
facturers Reports were to be submitted to the U.S. EPA Office of Toxic
Substances by November 19, 1982, for each of the trlchlorobenzenes (40 CFR
712).
The U.S. EPA determined that, on the basis of present Information, TCB
Is not classifiable as a human carcinogen; It therefore Is placed In Class
D. This decision was verified by CRAVE 1n October 1988 (U.S. EPA, 1991).
Transportation and Regulations. The export of 1,2,3- and 1,2,4-trl-
chlorobenzene 1s regulated by DOT through the use of the Commodity Control
List (15 CFR 399).
Solid Haste Regulations. The trlchlorobenzenes are designated as
hazardous constituents of hazardous wastes from specific sources subject to
RCRA disposal regulations (40 CFR 261.32). The hazardous waste In which the
03790 VIII-19 12/17/91
-------
trlchlorobenzenes are controlled as part of the hazardous constituents 1s
from the distillation or fractlonatlon column bottoms from the production of
chlorobenzene and Is designated as EPA Hazardous Waste No. K085.
Mater. The U.S. EPA (1980), In an Ambient Water Quality Criteria
Document for Chlorinated Benzenes, determined that "Reliable tox1co!og1cal
data on which to base a defensible water quality criterion do not exist for
the trlchlorobenzenes.11 As a result of this determination no criterion was
recommended for any trlchlorobenzene Isomer.
Special Groups at Risk
Only anecdotal Information regarding human exposure to trlchlorobenzene
1s available. These data do not Indicate special groups that might be at
risk.
Summary
Health advisories and a DWEL for 1,2,4-tMchlorobenzene In drinking
water, based on noncarclnogenlc toxlclty data, are given In Table VIII-3.
No HAs or DWELs are suggested for the 1,2,3- and 1,3,5-trlchlorobenzene
Isomers because of Insufficient data being available for evaluation. The
1-day HA for 1,2,4-tMchlorobenzene of 1 mg/s. for a 10 kg child 1s based
on a study by Arlyoshl et al. (1975c) 1n which female Wlstar rats were given
single oral doses of 1.2,4-tMchlorobenzene and were then evaluated. The
10-day HA for 1,2,4-tr1chlorobenzene of 1 mg/i for a 10 kg child 1s based
on a study by Carlson and Tardlff (1976) In which male CD rats were given
1,2,4-trlchlorobenzene for 14 days and were then evaluated. The longer-term
03790 VIII-20 01/03/92
-------
o
CO
TABLE VI11-3
Sumnary of the Data for 1.2.4-Trlchlorobenzene Used to Derive HAs and DUEL
Health Species/Route
Advisory
1-Oay rat/oral
10-Day rat/oral
Longer-term rat/oral
DWH rat/oral
Cdncer
potency
Dose Duration
(rag/kg bw/day)
12S single
dose
10 14 days
14.8 95 days/gen.
2 generations
14.8 95 days/gen.
2 generations
Value (mq/t)
Basis Uncertainty
factors Child Adult
NOAEL. higher doses 1000 1 NA
cause a greater number
of alterations
NOAEL. higher doses 100 1 NA
cause a greater number
of dose-related hepatic
changes
NOAEL. higher dose caused 100 1 5
Increased adrenal gland
weights
NOAEL. higher dose caused 1000 NA 0.4
Increased adrenal gland
weights
NR
Reference
Arlyoshl
el al.. 1975c
Carlson and
Tardiff. 1976
Robinson
et a).. 1981
Robinson
et al.. 1981
*for a 70 kg adult
"For a 10 kg child
NA = Not applicable; NR = none recomnended
o
GO
-------
HAs for 1,2,4-tMchlorobenzene of 1 mg/l for a 10 kg child and 5 mg/j.
for a 70 kg adult are based on a study by Robinson et al. (1981) In which
CD-I rats were exposed by gavage to 1,2,4-tMchlorobenzene for 95
days/generation for 2 generations and evaluated for reproductive effects and
adrenal gland changes. An oral RfD of 1E-2 mg/kg/day was derived from the
Robinson study. A DWEL for 1,2,4-tr1chlorobenzene of 0.4 mg/l for a 70 kg
adult was calculated from the same Robinson et al. (1981) study. The data
available on 1,2,4-tMchlorobenzene are Inadequate for making any
conclusions about Us potential cardnogenlclty In humans.
03790 VIII-22 01/03/92
-------
IX. REFERENCES
ACGIH (American Conference of Governmental Industrial Hyglenlsts). 1982.
Threshold Limit Values for Chemical Substances In Work Air Adopted by ACGIH
for 1982. Cincinnati. OH. ISBN: 0-936712-39-2.
Arlyoshl, T., K. Ideguchl, Y. Ishlzuka, K. Iwasakl and M. Arakakl. 1975a.
Relationship between chemical structure and activity. I. Effects of the
number of chlorine atoms In chlorinated benzenes on the components of
drug-metabolizing system and the hepatic constituents. Chem. Pharm. Bull.
23(4): 817-823.
Arlyoshl. T., K. Ideguchl, K. Iwasakl and M. Arakakl. 1975b. Relationship
between chemical structure and activity. II. Influences of Isomers In
dlchlorobenzene. trlchlorobenzene, and tetrachlorobenzene on the activities
of drug-metabolizing enzymes. Chem. Pharm. Bull. 23(4): 824-830.
Arlyoshl, T., K. Ideguchl. K. Iwasakl and M. Arakakl. 1975c. Relationship
between chemical structure and activity. III. Dose-response or time-course
of Induction In mlcrosomal enzymes following treatment with 1,2,4-trlchloro-
benzene. Chem. Pharm. Bull. 23(4): 831-836.
Berger, D.A. 1987. 1,2,4-TMchlorobenzene health-based maximum contaminant
level support document, in: Maximum Contaminant Level Recommendations for
Hazardous Contaminants In Drinking Water. Appendix B. Health-Based Maximum
Contaminant Level Support Documents. March 26, 1987. Section P.
03800 IX-1 08/20/87
-------
Black, W.D., V.E.O. Vall1. J.A. Ruddlck and D.C. Vllleneuve. 1983. The
toxldty of three trlchlorobenzene Isomers In pregnant rats. The Tox1-
cologlst. 3(1): 30. (Abstr.)
Brown, V.K.H., C. Mulr and E. Thorpe. 1969. The acute toxlclty and skin
Irritant properties of 1,2,4-trlchlorobenzene. Ann. Occup. Hyg. 12:
209-212.
Cameron, G.R., J.C. Thomas, S.A. Ashmore, J.L. Buchan, E.H. Warre/i and A.W.
McKlnney Hughes. 1937. The toxlclty of certain chlorine derivatives of
benzene, with special reference to o-dlchlorobenzene. J. Pathol. Bacterlol.
44(2): 281-296.
Carlson, G.P. 1977a. Halogenated benzenes, effect on xenoblotlc metabolism
and the toxlclty of other chemicals. Ann. N.Y. Acad. Scl. 298: 159-169.
Carlson, G.P. 1977b. Chlorinated benzene Induction of hepatic porphyMa.
ExpeMentla. 33(12): 1627-1629.
Carlson, G.P. 1978. Induction of cytochrome P-450 by halogenated benzenes.
Blochem. Pharmacol. 27(3): 361-363.
Carlson, G.P. 1980. Effects of halogenated benzenes on arylesterase activ-
ity Ui vivo and in vitro. Res. Commun. Chem. Pathol. Pharmacol. 30(2):
361-364.
03800 IX-2 08/20/87
-------
Carlson, G.P. 1981. Effects of halogenated aromatic compounds on the
metabolism of foreign organic compounds. U.S. EPA Health Effects Res. Lab.,
Cincinnati, OH. EPA-600/1-81-010. NTIS PB81-152522.
Carlson, G.P. and R.G. Tardlff. 1976. Effect of chlorinated benzenes on
the metabolism of foreign organic compounds. Toxlcol. Appl. Pharmacol. 36:
383-394.
Carlson, G.P.. J.D. Dzlezak and K.M. Johnson. 1979. Effect of halogenated
benzenes on acetanlllde esterase, acetanlllde hydroxylase and procalne
esterase 1n rats. Res. Commun. Chem. Pathol. Pharmacol. 25(1): 181-184.
Chlorobenzene Producers Association. 1984. Comments of the Chlorobenzene
Producers Association on the EPA Review Draft Health Assessment Document for
Chlorinated Benzenes. 49 Fed. Reg. 18616 (May, 1984) Part II. Submitted to
U.S. EPA, Environmental Criteria and Assessment Office, Cincinnati, OH on
July 30, 1984.
Clcmanec, J.L. 1991. Report of In-house research with
1.2,4-trlchlorobenzene; an acute animal study. Memorandum to the U.S. EPA
RfD/RfC Work Group. December, 1991.
Coate, W.B., U.H. Schoenflsch. T.R. Lewis and U.M. Busey. 1977. Chronic,
Inhalation exposure of rats, rabbits, and monkeys to 1,2,4-tMchlorobenzene.
Arch. Environ. Health. 32(6): 249-255.
03800 IX-3 01/03/92
-------
S.T.. G.F. Wolfe and C.C. Smith. 1918. Toxlclty of 1,2,4-trlchloro-
' 1-i Rhesus monkeys: Comparison of two in vivo methods for estimating
ct-'Hy. Toxlcol. Appl. Pharmacol. 45(1): 340. {Abstr.J
A., B. Leece, 3. Gyorkos and K. Homonko. 1383. PolychloMnated
.- : phenol congeners as Inducers of rat hepatic drug-metabolizing
n Immature male Hlstar rats. Can. J. Physlol. Pharmacol. 61:
1 Company. 1979-1980. Material safety data sheets - mono-
e, o-dlchlorobenzene, p-dlchlorobenzene, 1,2,4-trichlorobenzene,
achlorobenzene. Midland, HI.
. Orossman and T. Mill. 1986. Products and quantum yields for
F chloroaromatlcs In water. Environ. Scl. Technol. 20: 72-77.
jerova. V. and H.C. Hughes. 1983. Species differences on
ity of Inhaled vapors and gases. Chapter 4. In.: Modeling of
Exposure to Vapors: Uptake, Distribution and Elimination
Press, Boca Raton, FL.
F. Tolot, P. Martin and J. Bourret. 1969. Serious blood dls-
exposure to chlorine derivatives of benzene (A report of 7
•led. Lyon. 50(1164): 771-773. (Fre.)
Gllman. 1985. Goodman and Oilman's The Pharmacological Basis
ics, 7th ed. MacMlllan Publishing Company, New York. p. 358.
IX-4 01/03/92
-------
Goto, M., H. Hattorl, T. Mlyagawa and M. Enomoto. 1972. BeHrage zur
okologlschen chemle. II. Hepatoma-blldung 1n mausen nach verabrelchung von
HCH-lsomeren 1n hohen dosen. Chemosphere. 6: 279-282. (6er.)
Gurfeln, L.N. and Z.K. Pavlova. 1960. Maximum allowable concentration of
chlorinated benzene In water supplies. Sanlt. Okhrana Vod. Zagryaznenlya
Prom. Stochrayml Vodanrt. (4): 117-127. (Cited 1n CA 56:10601)
Hansch, C. and A.3. Leo. 1981. Medchem Project. Issue No. 19. Pamona
College, CA.
Hawley, G.G. 1977. Condensed Chemical Dictionary, 9th ed. Van Nostrand
Relnhold Company, NY.
Horvath, A.L. 1982. Halogenated Hydrocarbons. Solubility - MlsclbHlty
with Water. Marcel Oekker, Inc., NY. p. 530.
Jondorf, W.R., D.V. Parke and R.T. Williams. 1955. Studies In detoxlca-
tlon. 66. The metabolism of halogenobenzenes, 1,2,3-, 1,2,4- and 1,3,5-
tMchlorobenzenes. Blochem. 3. 61: 512-521.
Kao, C.I. and N. Poffenberger. 1979. Chlorinated benzenes. In.: Klrk-
Othmer Encyclopedia of Chemical Technology, 3rd ed., Vol. 5. John Wiley and
Sons. New York. p. 797-808.
KHchln, K.T. and H.T. Ebron. 1983. Maternal hepatic and embryonic effects
of 1,2,4-trlchlorobenzene In the rat. Environ. Res. 31: 362-373.
03800 IX-5 01/03/92
-------
Kodba, R.J., B.K.J. Leong and R.E. Hefner. Jr. 1981. Subchronlc toxldty
study of 1,2,4-trlchlorobenzene 1n the rat. rabbit and beagle dog. Drug
Chem. Toxlcol. 4(3): 229-249.
KohH. J.. 0. Jones and S. Safe. 1976. The metabolism of higher chlori-
nated benzene Isomers. Can. J. Blochem. 54(3): 203-208.
Kuehl, D.W., E.N. Leonard. K.J. Welch and G.D. Velth. 1980. Identification
of hazardous organic chemicals In fish from the Ashtabula River, Ohio, and
Wabash River, Indiana. J. Ass.oc. Off. Anal. Chem. 63(6): 1238-1244.
Langhorst, M.L. and T.J. Nestrlck. 1979. Determination of chlorobenzenes
In air and biological samples by gas chromatography with photolonlzatlon
detection. Anal. Chem. 51(12): 2018-2025.
Lawlor, T., S.R. Haworth and P. Voytek. 1979. Evaluation of the genetic
activity of nine chlorinated phenols, seven chlorinated benzenes, and three
chlorinated hexanes. Environ. Nutagen. 1: 143. (Abstr.)
Lewis, R.G. and K.E. MacLeod. 1982. Portable sampler for pesticides and
semlvolatlle Industrial organic chemicals In air. Anal. Chem. 54: 310-315.
L1ngg, R.D.. U.H. Kaylor, S.N. Pyle et al. 1982. Comparative metabolism of
1,2,4-tMchlorobenzene In the rat and Rhesus monkey. Drug Metabol. Dlspos.
10(2): 134-141.
03800 IX-6 01/03/92
-------
Lopez-Avlla, V., R. Northcutt. J. Onstot, M. Wlckham and S. Billets. 1983.
Determination of 51 priority organic compounds after extraction from stan-
dard reference materials. Anal. Chem. 55(6): 881-889.
MacKay, D., W.Y. Shlu and R.P. Sutherland. 1979. Determination of air-
water Henry's Law constants for hydrophobia pollutants. Environ. Sc1.
Techno!. 13(3): 333-337.
Matthews, M.B. and S. Kato. 1979. The metabolism and disposition of halo-
genated aromatlcs. Irr. Ann N.Y. Acad. Scl., Vol. 320. Health Effects of
Halogenated Aromatic Hydrocarbons, Int. Symp., NY, June 24-27, 1978, W.J.
Nicholson and J.A. Moore, Ed. N.Y. Acad. Scl. p. 131-137.
NAS (National Academy of Sciences). 1977. Drinking Water and Health. Safe
Drinking Water Committee, NAS, Washington. DC. p. 667-673, 798-799.
NAS (National Academy of Sciences). 1980. Drinking Water and Health. Vol.
3, p. 25-67.
NIOSH (National Institute for Occupational Safety and Health). 1978. Cri-
teria for a Recommended Standard...Occupational Exposure During the Manu-
facture and Formulations of Pesticides. Cincinnati, OH. DHEW (NIOSH) Publ.
No. 78-174.
NLM (National Library of Medicine). 1981a. 1,2,3-TMchlorobenzene. Toxi-
cology Data Base, Bethesda, MD. TDB No. 1502.
03800 IX-7 01/03/92
-------
NLH (National Library of Medicine). 1981b. 1,2,4-Trlchlorobenzene. Toxi-
cology Data Base, Bethesda, MD. TOB No. 1105.
NLM (National Library of Medicine). 1982. 1,3,5-Trlchlorobenzene. Toxi-
cology Data Base, Bethesda, MD. TDB No. 0132.
Oehtne, M. and H. Stray. 1982. Quantitative determination of ultra-traces
of chlorinated compounds 1n high-volume air samples from the Arctic using
polyurethane foam as collection medium. Fresenlus Z. Anal. Chem. 311(7):
665-673.
Parke, D.V. and R.T. Williams. 1960. Studies In detoxlcatlon. LXXXI. The
metabolism of halogenobenzenes: (a) penta- and hexa-chlorobenzenes. and (b)
further observations on 1,3,5-trlchlorobenzene. Blochem. J. 74: 5-9.
Powers, M.B., U.B. Coate and T.R. Lewis. 1975. Repeated topical applica-
tions of 1,2,4-trlchlorobenzene: Effects on rabbit ears. Arch. Environ.
Health. 30: 165-167.
Rao, K.S., K.A. Johnson and J.W. Henck. 1982. Subchronlc dermal toxldty
study of trlchlorobenzene 1n the rabbit. Drug. Chem. Toxlcol. 5(3):
249-263.
Rlmlngton, C. and G. Zlegler. 1963. Experimental porphyrla In rats Induced
by chlorinated benzenes. Blochem. Pharmacol. 12: 1387-1397.
03800 IX-8 01/03/92
-------
Rlnkus, S.J. and M.S. Legator. 1980. The need for both Ui vitro and In
vivo systems 1n mutagenlcHy screening. Ijn: Chemical Mutagens, Vol. 6, A.
Hollander, Ed. Plenum Press, New York. p. 365-473.
Robinson, K.S., R.J. Kavlock, N. Chernoff and L.E. Gray. 1981. Multlgener-
atlon study of 1,2,4-tMchlorobenzene In rats. J. Toxlcol. Environ. Health.
8(3): 489-500.
Rowe, V.K. 1975. Written communication. (Cited 1n U.S. EPA, 1980)
Sasmore, D.P., C. Mltoma, C.A. Tyson and J.S. Johnson. 1983. Subchronlc
Inhalation toxldty of 1,3,5-tMchlorobenzene. Drug. Chem. Toxlcol. 6(3):
241-258.
Sax. N.I. 1979. Dangerous Properties of Industrial Materials, 5th ed. Van
Nostrand Relnhold Co.. NY. p. 716.
Schoeny. R.S., C.C. Smith and J.C. Loper. 1979. Non-mutagen1c1ty for Sal-
monella of the chlorinated hydrocarbons Arochlor 1254, 1,2,4-tMchloroben-
zene, ml rex and kepone. Mutat. Res. 68(2): 125-132.
Sllmak, K., P. Johnson and V. Hodge. 1980. Materials balance-task a4
chlorobenzenes. U.S. EPA, Office of Toxic Substances, Washington, DC.
EPA-560/13-80-001.
Smith, E.N. and G.P. Carlson. 1980. Various pharmacoklnetlc parameters 1n
relation to enzyme-Inducing abilities of 1,2,4-trlchlorobenzene and
1,2,4-trlbromobenzene. J. Toxlcol. Environ. Health. 6(4): 737-749.
03800 IX-9 01/03/92
-------
SmHh, C.C., S.T. Cragg and G.F. Wolfe. 1978. Subacute toxlclty of
1,2,4-trlchlorobenzene (TCB) 1n subhuman pr_1mates. Fed. Proc. 37(3): 248.
Townsend, B.A. and G.P. Carlson. 1981. Effect of halogenated benzenes on
the toxlclty and metabolism of malathlon, malaoxon, parathlon and paraoxon
In mice. Toxlcol. Appl. Pharmacol. 60(1): 52-61.
Treon, J. 1950. The toxlclty of tMchlorobenzene. Ketterlng Lab., Univ.
of Cincinnati. (Unpubl. rep.) (Cited 1n Coate et al.. 1977)
U.S. EPA. 1980. Ambient Water Quality Criteria Document for Chlorinated
Benzenes. Prepared by the Office of Health and Environmental Assessment.
Environmental Criteria and Assessment Office. Cincinnati. OH for the Office
of Water Regulations and Standards. Washington, DC. EPA 440/5-80-028. NTIS
PB 81-117392.
U.S. EPA. 1982. Test Methods: Methods of Organic Chemical Analysis of
Municipal and Industrial Wastewater, J.E. Longbottom and J.J. Llchtenberg,
Ed. Environ. Monlt. Sup. Lab., Cincinnati, OH. EPA 600/4-82-057. NTIS
PB83-20-1798.
U.S. EPA. 1983. Chlorinated benzenes aggregates derived from Information
reported under TSCA section 8(a). Preliminary assessment Information rule
(47 FR 26992) using the techniques for aggregating data described by 48 FR
27041. Office of Toxic Substances. Washington, DC.
03800 IX-10 01/03/92
-------
U.S. EPA. 1985. Health Assessment Document for Chlorinated Benzenes.
Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office. Cincinnati, OH. EPA 600/8-84/015F. NTIS PB 85-150332.
U.S. EPA. 1986. Guidelines for Carcinogen Risk Assessment. Federal
Register. 51(185): 33992-34003.
U.S. EPA. 1991. Integrated Risk Information System (IRIS). Online.
Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office, Cincinnati, OH.
Verschueren, K. 1977. Handbook of Environmental Data on Organic Chemicals.
Von Nostrand Relnhold Co., New York.
Warner, H.P., J.M. Cohen and J.C. Ireland. 1980. Determination of Henry's
Law Constants of Selected Priority Pollutants. U.S. EPA Research Report.
Cincinnati, OH. EPA/600/D-87/229. NTIS PB87-212684.
Watanabe, P.G., R.J. Koclba, R.E. Hefner, Jr., H.O. Yakel and B.K.J. Leong.
1978. Subchronlc toxldty studies of 1,2,4-trlchlorobenzene In experimental
animals. Toxlcol. Appl. Pharmacol. 45(1): 332-333.
Williams, R.T. 1959. The metabolism of halogenated aromatic hydrocarbons.
jhn: Detox1cat1on Mechanisms, 2nd ed. John Wiley and Sons, New York.
p. 237-277.
Yalkowsky, S.H. and S.C. Valvanl. 1980. Solubility and partitioning. I.
Solubility of nonelectrolytes 1n water. J. Pharm. Set. 69(8): 912-922.
03800 IX-11 01/03/92
-------
Yamamoto, H., Y. Ohno, K. Nakamorl, T. Okuyama, S. Imal and Y. Tsubura.
1982. Chronic toxlclty and carclnogenlclty test of 1,2,4-trlchlorobenzene
on mice by dermal painting. J. Nara. Med. Assoc. 33: 132-145. (Jap.)
Yang, K.H., R.E. Peterson and J.M. Fujlmoto. 1979. Increased bile duct-
pancreatic fluid flow In benzene and halogenated benzene-treated rats.
Toxlcol. Appl. Pharmacol. 47(3): 505-514.
03800 IX-12 01/03/92
------- |